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Abstract 
Epithelial-derived podocytes are essential for establishing the glomerular filtration 
barrier by providing and sustaining the slit diaphragm, which is dependable on the 
development and maintenance of the polarised cell body structure of the podocyte.  
This work was therefore aimed at investigating the importance of the Crumbs 
complex polarity proteins, Crb3 and Pals1, in mature and developing podocytes. 
Expression of Crb3 and Pals1 in podocytes and glomeruli was demonstrated via 
staining of murine and human kidney sections, and by mRNA analysis. A strong 
expression of Crb3b led to investigations of both isoforms in immortalised human 
podocyte cell line (AB8). Additionally, the cytoplasmic tail of Nephrin was used to 
investigate a possible dependence between slit diaphragm proteins and Crumbs complex. 
Overexpression analysis of Crb3a, Crb3b or the C-terminal part of Nephrin showed an 
induction of junction-like structures with co-localisation of tight junction marker ZO-1, 
while a simultaneous overexpression of two of them indicated a possible dependence of 
expression and cellular localisation, with Nephrin being dominant over Crb3 and Crb3b 
being dominant over Crb3a. In a cyst formation assay both Crb3 isoforms induced an 
increased cyst growth, further underlining the fact, that Crb3a and Crb3b seem to have a 
similar influence in podocytes, despite their different C-terminal region. 
A possible link between Pals1, a major interaction partner of Crb3a, and Crb3b 
was assumed in podocytes, but could not be confirmed.  
Mouse in vivo analysis of a conditional knockdown of Pals1 in podocytes revealed 
no obvious changes in the glomerular structure and no proteinuria, assuming a still 
functioning slit diaphragm. However, another in vivo approach of a conditional Pals1 
knockdown during the development of the nephron demonstrated a strong phenotype 
with impairments of body size and weight, a development of severe proteinuria within 2 
weeks after birth, a median survival of only 40 days, a development of cystic cavities in 
the kidney and drastic pathological changes of the glomerulus. 
Taken together these data suggest that Crb3 plays a role in podocytes, but for 
further elucidation of how far they are involved in podocyte regulations, in vivo studies 
might be a unavoidable. However, a significant role for Pals1 in the development of the 
nephron was demonstrated.  
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1 Introduction 
1.1 Kidney Function and Nephron Development 
The kidneys are complex reprocessing organs. They have essential regulatory 
roles like regulation of electrolytes (e.g. sodium, calcium), blood pressure, osmolarity 
and, furthermore, production of hormones like renin and sieving of waste products e.g. 
ammonium and urea. In fact, they are the body´s natural filter of the blood. By 
generating 180 litre of primary urine per day, the kidneys remove a large quantity of 
metabolic wastes. At the same time, they reabsorb vital nutrients like water, amino acids 
and electrolytes form the primary urine, concentrating it to a final volume of 
approximately 2 litres leaving the body daily.1,2 The actual production of primary urine, 
thus the removal of wastes occurs in small units called nephrons. 
The mammalian kidney derives from the intermediate mesoderm. After the 
temporary formation of the pronephros (without function) and the mesonephros 
(temporary filtration function), the metanephros (adult kidney) develops (Fig.1). The 
adult kidney development begins when remainder of the mesonephros - the Wolffian 
duct - forms a bulge called the ureteric bud. The ureteric bud epithelia invades the 
adjacent metanephric mesenchyme inducing branching morphogenesis. At the branching 
ureteric bud tips, mesenchymal cells aggregate and begin the mesenchyme-to-epithelial 
transformation (MET) process, forming a polarized renal vesicle.3–5 
All epithelial cells of the developing nephron arise from these renal vesicles. While 
the polarized renal vesicle first creates a single cleft (comma-shaped body), then a 
second cleft (s-shaped body), the ureteric bud continues to branch and generate new 
mesenchymal cell aggregates (Fig.1b). Going through these morphological stages of 
comma- and s-shaped body formation, metanephric tubules arise from these renal 
vesicles maturing into the tubular system forming proximal and distal tubules as well as 
glomerular components (Fig.1c).6,7  
The proximal end of the renal vesicle forms the glomerulus while the distal end 
fuses with the ureteric bud to form a single, continuous epithelial tubule (Fig.1b). During 
the s-shaped stage the first podocytes appear and a vascular cleft arises, subsequently 
developing into the Bowman´s capsule, into which vascular endothelial cells migrate. 
These endothelial cells proliferate, aggregate and consequently form the first capillary 
loop. This first capillary loop divides into 6-8 loops during maturation.4,6  
As the glomerulus matures, the glomerular filtration barrier is established by three 
components: the developing glomerular basement membrane (GBM), the endothelial 
cells differentiating and acquiring a fenestrated morphology, and the podocytes 
extending themselves around the capillary loops while undergoing an extensive 
transformation with a mesenchymal-to-epithelial transition.7,8  
 ________________________________
 
Figure 1: Nephrogenesis and anatomy of the kidney.
interactions of the mesonephric duct and the metanephric mesenchyme, giving rise to the ureter. At embryonic 
stage E11.5, the ureter invades and branches once in the mesenchyme. (B) Branching morphogenesis is 
induced by ureteric tip epithelia invading the adjacent metanephric mesenchyme. A series of morphological 
transformations occurs: (1) condensation of mesenchymal cells; (2) fo
mesenchymal-to-epithelial transition; (3) formation of the comma
finally the formation of the glomerulus and nephron. 
kidney.(modified from9) 
The GBM is the structural anchor for endothelial
endothelium attached to the lamina interna and the podocytes to the lamina externa. It 
consists mostly of type IV collagen, laminin and heparan sulfate proteoglycans.
assembly of endothelial cells 
These are covered with a negatively charged glycocalyx
hindrance for the passage of albumin and o
charge selectivity.12,13 The most essential 
are the podocytes and the slit diaphragm they generate.
Podocytes are highly polarised 
Differentiated podocytes arise fr
along their lateral membranes. 
attachment, except for their conn
contacts - tight and adherens junction
Meanwhile, they begin to form major processes and foot processes, which interdigitate 
along the basal area and anchor themselves into the glomerular bas
This leads to a detachment of the podocyte´s cell body and major processes. The l
maturation step induces the change of unspecific intercellular junctions between adjacent 
foot processes into highly specific slit diaphragms
1.2 Cell Polarity in Epithelial Cells
As already mentioned, the development of the nephron during nephrogen
tightly connected to the polarisation of cells derived from the renal vesicle, transforming 
the mesenchymal cells to specialised 
_____________
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tubuli. Cell  polarity is essential for elementary cell processes, including cell proliferation, 
differentiation and morphogenesis, and is highly dependent on the generation of 
junctional cell-cell contacts, like tight and adherens junctions, as well as the asymmetric 
distribution of biomolecules (proteins, lipids, carbohydrates), organelles, membrane and 
cytoskeletal compartments within a cell.15–17 Due to this asymmetry, there are two 
plasma membrane domains to be distinguished in epithelial cells: the apical domain 
facing the lumen and the basolateral domain including the basal domain attached to the 
basement membrane and the lateral domain connected to neighbouring cells. Each 
domain has a characteristic protein and lipid composition based on its function in cell 
processes, including absorption, secretion and transcellular transport.18,19 
1.2.1 The Par Complex 
The first identified proteins connected to polarity formation were the partitioning 
defective (Par) proteins, based on the asymmetric divisions occurring in the nematode 
Caenorhabditis elegans zygote. Par3 and Par6, scaffold proteins with PDZ (PSD-95/Disc 
large/ZO-1) domains, are located at the anterior cortex in the C. elegans one-cell 
embryo, while Par1, a protein kinase, is found at the posterior cortex.20,21 Mutations in 
these proteins led to defects in cell division.22 Later on, another Par gene coding for an 
atypical protein kinase C (aPKC) was discovered to interact with Par3.23 Studies in 
Drosophila melanogaster and vertebrates discovered Par homologue genes leading to the 
concept of the first polarity protein complex Par3/Par6/aPKC conserved from worms to 
mammals.24–27 
Par3 is a multi-domain scaffold protein with three PDZ domains able to interact 
with Par6 and aPKC (Fig.2).28 Interaction with aPKC leads to Par3 phosphorylation that is 
required for proper tight junction formation.28 Additionally, the phosphorylation of 
another Par3 serine by Par1 promotes the binding of 14-3-3 proteins that function as 
“phospho-protein-adaptors”, keeping Par3 off the lateral membrane. Furthermore, it 
seems that upon generation of new cell-cell contacts Par3 plays the role of a scaffold in 
the recruitment of Par6 and aPKC to the forming junction.29,30  
Par6 is another scaffold protein with a Phox and Bem1 (PB1) domain for binding 
aPKC, a Cdc42/Rac Interactive Binding (CRIB) domain, and a C-terminal PDZ domain for 
binding Pals1, Crb3 or Par3 (Fig.2).28,31,32 The key function of Par6 is to enable an 
interaction between aPKC and its downstream effectors, Par3 and Lgl (Lethal giant 
larvae). Binding of Lgl through Par6 leads to Lgl phosphorylation by aPKC, which 
promotes Par3/Par6 interactions.28  
 ________________________________
 
Figure 2: The apical polarity core complexes.
and interactions of the Par and Crumbs complexes. Protein interaction  domains are represented by filled 
shapes. Crb3 is the only transmembra
PDZ binding motif (blue) with Pals1 and Par6. Interactions are indicated by double
Furthermore, an interaction between Cdc42 and Par6 resul
change of Par6, which alters the binding to 
An important role of the two scaffold proteins 
and regulation of the serine/threonine kinase aPKC, a core effector of the complex. 
Atypical PKCs (aPKCλ/ι and aPKCζ
domain, allowing direct interact
members at the tight junction
Darby canine kidney cells).26
polarity, which is established by t
Through this highly conserved
including Par3, Par-1 and Lgl. Phosphorylation of lateral proteins Par
their exclusion from the apical membrane, thereby preventing their mislocalisation at the 
tight junction.36–38  
Several studies present data emphasising the role of the Par complex in 
establishment of cell polarity. For example, a missing phosphorylation of Par3 and thus 
lacking interaction with 14
overexpression of Par3 in epithelial cells results in tight junction disruption and 
mislocalisation of aPKC and Par6.
formation of the tight junction, since 
development, and mislocalisation of Par3.
was found to be part of a complex with the small GTPase Cdc42.
from canine tubule cells, Cdc42 was found to be necessary for the correc
localisation and normal cell p
_____________
 Shown is a schematic overview of the composition 
ne protein of the two apical protein complexes. Crb3 interacts through its 
-headed arrows.
ts in a conformational 
other apical polarity proteins like Pals1.
Par3 and Par6 
) have, in contrast to conventional PKCs
ion with Par6.35 They are localised with other Par complex 
s of mammalian epithelial cells, e.g. in MDCK cells (Madine 
 Their primary role in cells is the mediation of apicobasal 
he catalytic domain within the C
 domain, aPKC phosphorylates several polarit
-
-3-3 results in polarity defects.38–
41,42 The aPKC kinase activity is required for the 
inactive aPKC evokes to blockage of
43 Additionally, the mammalian Par complex 
28 In MDCK
olarisation.44 E-cadherin mediated cell
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activates Cdc42, leading to a phosphorylation and the correct translocation of aPKC from 
the nucleus to the cytoplasm and cell periphery.45,46  
1.2.2 The Crumbs Complex 
However, the Par complex is not the only conserved polarity complex. In 
Drosophila the mutation of a newly identified gene, found to be localised exclusively at 
the apical domain and cell borders, led to a crumbled cuticle abnormality, therefore 
named Crumbs.47,48 Hollander et al. discovered a homology between Drosophila Crumbs 
(DCrb) and a mutated gene in human retinis pigmentosa (RP) disease, terming it 
Crumbs1 (Crb1), illustrating the evolutionary conserved status of Crbs.49  
In contrast to all other polarity proteins the Crumbs protein family encodes the 
only single span transmembrane protein (Fig.2).48 Studies confirmed only one Crumbs 
protein in Drosophila (DCrb), but three mammalian Crumbs genes, of which Crb1 and 
Crb2 posses a large extracellular domain like DCrb, including 3 Laminin A/G domains and 
19 (Crb1) and 14 (Crb2) EGF-like domains and a highly conserved intracellular tail.49–53 
Mammalian Crb1 and Crb2 are mainly expressed in retina and brain, with Crb2 also being 
present in the kidney, and while the function of Crb2 is not yet fully understood, it has 
recently been shown to play a role in the establishment of polarity in zebrafish 
podocytes.51,52,54 Mutations in Crb1 cause retinal diseases with progressive degeneration 
of photoreceptors, including leber congenital amaurosis (LCA) and retinis pigmetosa (RP), 
indicating a role of Crb1 in the maintenance of retinal cell polarity.49,55  
The third mammalian Crumbs gene is mainly expressed in skeletal muscle and all 
epithelial tissues, and represents the predominant form in the kidney. Crb3 has a 
non-conserved short extracellular domain including O and N-glycosylation sites, but no 
discernible protein domain.32,50,56 All three members of the Crumbs family (Crb1-Crb3) 
share a highly conserved intracellular region with two domains: a FERM (4.1 ezrin radixin 
moesin protein) binding domain consisting of 12 amino acids with a GTY motif and a PDZ 
domain at the C-terminus (Fig.3, A).57 FERM is a protein-protein binding domain found in 
various proteins, many serving as adapters linking transmembrane proteins to the 
cortical actin skeleton.58 Only few interaction partners have been discovered for the FERM 
domain so far, among them are Moe in zebrafish, Yurt in Drosophila and the two Yurt 
orthologous Epb4.1 and EHM2 in mammals.59–61 Additionally, Crb3 has a second isoform, 
which exists due to alternative splicing of the fourth and final exon, resulting in a 
divergent 23 amico acid sequence at its C-terminus and altering the sequence of the PDZ 
binding domain from ERLI (Crb3a) to CLPI (Crb3b; Fig.3).62 The ERLI motif of Crb3a has 
been shown to recognise Pals1 and Par6 via their PDZ domains which is essential for the 
proper localisation of aPKC (Fig.2).32,63 
 ________________________________
 
Figure 3: Crb3 isoforms and their protein interaction domains.
small extracellular region without 
binding domains: the common FERM domain (p
domains ERLI in Crb3a (orange) and CLPI in Crb3b (pink). (B) The amino acid sequence of the intracellular tail 
of Crb3a and Crb3b shows the highly conserved amino acids (bold letters) in the FERM 
Mammalian Crb3b is generated due to splicing of the last exon, leading to an alternative C
domain in Crb3b (red letters). (modified from
Endogenous Crb3a localises 
cilia.32,50,65 Overexpression of Crb3a in epithelial cells 
apical domain, extended tight junctions and a re
it leads to a delay in the recruitment
tight junction protein) and ZO
Crb3a lacking the ERLI motif 
correct targeting of Crb3a to the apical membrane. Therefore,
interactions of the Crb3a PDZ domain with Pals1 and Par6 are crucial for proper tight 
junction assembly.32,66  
The role of Crb3b has only 
far. The change in the PDZ 
Both isoforms localise to the apical domain a
Crb3b also localises to spindl
division and cytokinesis with a multinuclear phenotype, Crb3a knockdown shows no 
impact on cell division.62 However, knockdown of Crb3a results in an extensive loss of 
already established tight junctions, delay in 
calcium switch and a loss of cilia.
since knockdown of either isoform leads to a loss of cilia.
for both isoforms in epithelial formation and function, but probably with regard to tis
related functions. 
Interestingly, Par6 overexpression in MDCK cells leads to a delay in tight junction 
formation similarly to Crb3a overexpression phenotype and knockdown of Par3 results in 
_____________
 (A) Crb3a and Crb3b have a 
characteristic protein domains. The intracellular tail has highly conserved 
urple), a proline-rich domain in Crb3a (green), and the PDZ 
62,64) 
to the tight junctions, apical membrane and p
correlates with an expansion of the 
duced basolateral domain. Furthermore, 
 of tight junction markers PATJ (Pals1
-1 (zonula occludens-1). Intriguingly, an overexpression of 
has no influence on tight junction formations but on a
 it is assumed
been described to play a role during ciliogen
binding motif to CLPI obviously alters the function of Crb3
nd primary cilium of MDCK cells. W
e poles of mitotic MDCK cells and a knockdown disrupts cell 
de novo establishment of tight junctions after 
65,67 Thus, both isoforms are required for ciliogenesis, 
62 This indicates an essential role 
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shorter cilia. This suggests 
transmembrane protein Crb3a and the ciliary axoneme, further emphasising the crucial 
role of Crb3 in tying the Par complex.
Accordingly, correct 
polarity through ciliogenesis, tight junction formation and preservation, and binding 
the Par complex. 
One if not the most importan
as an interaction partner of DCrb in 
led to a similar developmental defect as in DCrb mutations,
genetic pathway, with Std being downstream of DCrb.
Stardust, Protein associated with Lin
subfamily member 5), was first cloned as a new binding partner
multi-domain adaptor protein with 
L27 domains, a PDZ domain, a Src homology 
(GUK) domain (Fig.4).63,70  
Figure 4: Pals1 protein domains.
which interact with PATJ and Lin-7, respectively, one PDZ domain (red) for binding Crumbs
(green) and one GUK (blue) domain. Par6 interacts with the N
Pals1 interacts with transmembrane protein Crumbs via
with PATJ via its first L27 domain.
of Pals1 connects the Crumbs complex to the Par complex
moderate levels of Pals1 were found in brain, heart and skeletal muscle, but quiet high 
levels in placenta and kidney. In fully polaris
junction.70 Knockdown of Pals1 in epithelial cells demonstrated no 
but resulted in a loss of PATJ
junctions. A rescue experiment using an ectopically expressed Pals1 mutant lacking the 
L27 domain could not re-establish the PATJ expression level
is necessary for Pals1 to be targeted at the tight junction via its interaction with P
Consequently, Pals1 contributes to 
Pals1 knockdown affected the trafficking of E
defects in adherens junction formation, whereas 
_____________
a model with Par3 acting via Par6 as a linker between the 
68 
Crumbs expression and interactions are essential for 
t interaction partner of Crumbs was first discovered 
Drosophila, termed Stardust (Std). 
 suggesting 
69 The mammalian homologue of 
-7 1 (Pals1, also termed MPP5 for MAGUK p55 
 for Lin
several distinct protein interacting domains: a pair of 
3 (SH3) domain, and a guanylate kinase 
 Pals1 is composed of several domains: two L27 domains (y
-term of Pals1. 
 their PDZ domains and 
71 Furthermore, the binding of Par6 to the N
 (Fig.4
ed MDCK cells Pals1 locali
effect on
 expression as well as a disability of aPKC to target 
, proving that the L27 domain 
PATJ and tight junction stabilisation.
-cadherin to the lateral surface leading to 
PATJ or Crb3 knockdown did not.
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PATJ, in addition to Crb3 and Pals1, is considered to be the third member of the 
Crumbs polarity core complex. As a multi-PDZ domain protein PATJ serves as a scaffold 
protein, with four PDZ domains in Drosophila and ten in mammals. PATJ is mainly 
expressed in brain, testis, kidney, colon and lung, and is targeted to the tight junction 
and apical region of polarised cells.73,76 As previously described, it interacts with Pals1 via 
its L27 domain, and through its numerous PDZ domains with various junction 
components like claudin-1 and zonula occludens-3.63,77,78  
Downregulation or overexpression of PATJ in epithelial cells affects tight junctions 
by disrupting the localisation of ZO-1, ZO-3 and even occludin, but has no effect on the 
adherens junctions. Furthermore, the loss of PATJ results in the mislocalisation of Pals1 
and an accumulation of Crb3a in the early endosomal network, but interestingly, this has 
no remarkable effect on the protein levels of Pals1 and Crb3 in epithelial cells.34,73,74 
These data strongly suggest that PATJ plays a significant role in connecting the lateral 
(ZO-3 and occludin) and the apical (Pals1 and Crb3) components of the tight junctions, 
thereby stabilising the Crumbs complex.  
1.2.3 The Scribble Complex 
The Par complex and the Crumbs complex are the two apical core polarity 
complexes. Next to them is a third complex defining the basolateral domain. Due to the 
varying composition in different tissues and species, the role and importance of the 
basolateral complex is not yet determined.79 In Drosophila the basolateral complex is 
composed of the proteins Scribble (scrib), Lethal giant larvae (Lgl), and Discs large (Dlg). 
Defects in any of these proteins induces loss of polarity and tissue overgrowth.80 
Mammalian Lgl interacts with the Par complex, leading to the restriction of Lgl to the 
basolateral domain. Knockdown of Lgl in mice induces possible neuronal polarity 
defects.81 Dlg as well as Scribble seem to aid in adherens junction formation, but while 
the effect of Dlg knockdown is quite small, the loss of Scribble alters the stability of the 
adherens junction. Still, its role in apicobasal polarity is not yet fully determined.36,81  
1.2.4 Tight and Adherens Junctions 
Coordinated interaction of these complexes is required to regulate and define the 
diverse membrane domains, but additionally, the apical core complexes initiate and 
control the establishment of intercellular junctions like the tight junction (TJs) and the 
adherens junction (AJs) in epithelia, in order to preserve the asymmetrically distributed 
molecules and compartments and essentially the cell´s polarity.82,83 
The tight junctions, also zonula occludens, connect the membranes of adjacent 
cells, providing a fence function by separating the different membrane domains within a 
cell and a diffusion barrier by creating a seal between epithelial cells.84,85 They are mainly 
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composed of three transmembrane families: claudins, occludins, and junctional adhesion 
molecules (JAM).82  
Other essential tight junction associated proteins are CD2AP, CASK, MAGI1-2 and 
zonula occludens (ZO-1, 2 and 3) proteins. ZOs belong to the membrane-associated 
guanylate kinase (MAGUK) family of proteins and act as peripheral membrane scaffolding 
proteins.86 ZO-3 interacts with PATJ, an important member of the Crumbs polarity 
complex.77 The importance of ZOs for tight junction formation is shown in studies done 
with cells derived from ZO-1 knockout mice which show delayed tight junction 
formation.87 The adhesion junction, also zonula adherens, lays basal to the tight junction 
in mammalian epithelial cells and its primary structural components are cadherins and 
catenins. Cadherins are calcium-dependent transmembrane proteins serving as adhesion 
and signal transduction molecules, while catenins link cadherins to the actin 
cytoskeleton.88 
Furthermore, these junctional complexes are more than barriers, they represent 
highly dynamic structures associated with various adaptor proteins and signalling 
elements, connecting the junctional complexes to cellular processes such as proliferation, 
differentiation, migration, and quite importantly cell polarity.33  
1.3 Renal Pathologies and the Podocyte 
The evolutionary highly conserved polarity and junctional complexes specify 
polarity in diverse polarised cells and the mammalian kidney has a variety of epithelial 
cells, including tubular epithelial cells with classic tight and adherens junctions, and 
podocytes with a modified junction.  
A lot of renal dysfunctions are associated with the loss of polarity due to 
epithelial-to-mesenchymal transition (EMT, antagonism to MET).89 This dedifferentiation 
is in general accompanied by erroneous distribution of membrane components, including 
ion transporters/channels and matrix receptors, disruption of polarised adhesion 
junctions, reorganisation of the cytoskeleton and often pathological proliferation.19 For 
instance, glomerulopathies and tubulopathies are the most common causes for end-stage 
renal diseases (ESRD), caused by congenital and acquired damages of the nephron.90 
Tubulopathies, including polycystic kidney diseases like autosomal dominant polycystic 
kidney disease (ADPKD) and nephronophthisis, show tubular polarity defects leading to 
improper secretion into the nephron lumen instead of reabsorption, subsequently 
resulting in the formation of fluid-filled cysts.91,92   
However, almost 80% of ESRD are caused by glomerulopathies.90 Glomerular 
diseases, including congenital nephrotic syndrome of the Finnish type (CNSF), focal 
segmental glomerulosclerosis (FSGS), and HIV-associated nephropathy are examples 
characterised by the podocyte´s dedifferentiation and loss of polarity, leading to foot 
 ________________________________
 
process effacement, detachment from the glomerular basement membrane, proliferation 
and fibrosis (Fig. 5).93 
Figure 5: The spectrum of podocyte disease.
environmental factors leads to glomerular diseases. The clinical 
their impact on the glomerulus is. The clinical syndromes associated with podocyte dysfunction include: diffuse 
mesangial sclerosis (DMS), congenital nephrotic syndrome of the Finnish type (CNSF), Alport´s syndrome, 
minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), 
(Collapsing GN), immune and inflammatory glomerulonephropathies (Imm/Inf GN), hypertensive nephropathy 
(HTN), diabetic glomerulonephropathy (Diab GN), and age associated glomerulonephropathy (aging). Together 
they account for 80% of ESRD. (modified from
The healthy post-mitotic p
in the urinary space, and the foot processes firmly attached to the GBM through inte
and dystroglycans (Fig.6). 
epithelial cell type, is the fact that, contrary to common epithelial cells, the 
of the podocyte comprises an apical membrane domain,
processes and most of the foot processes
domain tightly attached to the GBM
junction (slit diaphragm). This structure has a similar protein composition to t
and adherens junction normally found in epithelial cells
protein structure serving extracellularly as a physical barrier for protein filtration and 
intracellularly as a signalling platform for critical control of actin dynamics, injury 
response, cell viability and cell polarity.
Nephrin, Podocin and Neph proteins 1
junction (ZO-1) and adherens junction proteins (cadherin, catenin)
development during nephrogenesis from a typical epithelial cell with tight and adherens 
junctions to a specialised cell with a slit diaphragm instead
_____________
 
 The podocyte dysfunction caused by genetic and/or 
manifestation depends on when and how severe 
collapsing glomerulonephropathy 
90) 
odocyte consists of a cell body, major processes float
What makes the podocyte a rather special and unusual 
 including the cell body
 (Fig.6b). There is only a very small basal 
 of the foot processes, forming 
 (Fig.6c).94 The slit diaphragm is 
95 It is composed of podocyte specific proteins like 
-3, while at the same time it contains typical tight 
.96–100 
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Figure 6: The podocyte´s morphology and slit diaphragm structure.
microscopy from the urinary space shows the podocyte
interdigitating foot processes covering the capillaries.
podocyte´s body and major processes float
attached to the gomerular basement membrane (GBM)
barrier reveals the fenestrated endothelium, the GBM and the secondary foot processes (pe
are attached through their basolateral membrane domain
junction (SD: slit diaphragm) between adjacent podocytes.
Loss of polarity, thus d
structural and functional loss of the slit diaphragm 
podocyte depletion in the glomerulus
substitution due to their post
neighbours or compensate for glomerular enlargement by hypertrophy
extent, but in most cases that is not sufficient.
following podocyte-loss hypothesis: regardless of the initial impact on the glome
(immune, toxic, infectious etc.), the outcome depends solely on the amount of depleted 
normal mature podocytes.90 
A significant loss of podocytes means that the glomerulus is not able to recover 
normal structure and function, which is associated with a progressive glomerulosclerosis, 
ultimately leading to a progressive loss of renal function and chronic kidney disease.
There are different degrees of podocyte loss described. A depletion of less than 20% 
podocytes in a glomerulus results only in a mesangial expansion, while
than 20% exposes areas of the GBM leading to segmental sclerosis. With
loss of podocytes the glomerulus becomes more sclerotic until a loss of more than 60% 
results in global sclerosis and 
degrees of proteinuria.103,104 
_____________
´s enormous cell body, major processes and 
 (B) Transmission electron microscopy 
ing in the urinary space, while the secondary foo
 of the capillary. (C) A cross section of the filtration 
 to the GBM. They generate a specialised cell
 (modified from94) 
edifferentiation due to injury or damage
and is one of the 
. Since having only a limited capacity for 
-mitotic state, podocytes are only able to replace lost 
93,101,102 Wiggins et al.
filtration dysfunction of the glomerulus with corresponding 
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1.4 Principal Objectives of this Work 
The loss of cell polarity and a dramatic change of the morphological architecture 
of the podocyte is a key feature of all glomerular diseases. A damaged podocyte, 
especially injuries affecting the slit diaphragm, results in massive proteinuria, clinically 
progressing to a nephrotic syndrome and end stage renal disease.94  
Podocytes exhibit an extensive apical domain as well as an indispensable slit 
diaphragm derived from tight and adherens jucntions, and studies proved the Crumbs 
complex to be essential for the development as well as maintenance of cell polarity in 
different epithelial tissues, especially in regards to the determination and preservation of 
the apical membrane domain and junction formations.32,49,54,65,66,79,105 Therefore, this 
work focused on the possible function of Crb3 and Pals1 in podocytes.  
The first part of this work aims at understanding the differences between Crb3a 
and Crb3b and their connection to the slit diaphragm. Therefore, kidney section staining 
and RNA studies were undertaken to prove the expression and localisation of the Crumbs 
complex proteins in glomeruli and podocytes. Afterwards, tagged constructs of Crb3a, 
Crb3b and C-terminal Nephrin were overexpressed in human podocytes (AB8) and Madin 
Darby canine kidney (MDCK) cells in order to investigate their localisation, possible 
function and interactions between them. 
The second part of this work focused on the Pals1 function in mature and 
developing podocytes in order to survey the importance of Pals1 for the establishment 
and the preservation of cell polarity in kidney epithelia. For that purpose, conditional 
knockdown mice were crossed with podocyte-specific and kidney developmental-specific 
Cre recombinase mice and subsequently analysed. 
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2 Materials 
2.1 Equipment 
Equipment Type Supplier 
Autoclave Varioklav 
H+P Labortechnik GmbH, 
Oberschleissheim 
Bacterial culture incubator B5050 Heraeus, Hanau 
Bacterial incubator shaker Certomat® IS 
B. Braun Melsungen AG, 
Melsungen 
Bunsen burner Lötmeister 3000 
CFH Löt-und Gasgeräte GmbH, 
Offenau 
Cell culture incubator 
Heracell 240 
 
MCO-20AIC 
Heraeus, Hanau 
 
Sanyo Electric Co., Ltd., Japan 
Centrifuges 
Mikro 200 R 
 
Allegra™ X-22R 
 
Multifuge 3S-R 
Megafuge 1.0R 
Hettich GmbH & Co.KG, 
Tuttlingen 
Beckman Coulter GmbH, 
Krefeld 
Heraeus, Hanau 
Heraeus, Hanau 
Chemiluminescent signal 
analyser 
Lumi-Imager F1 
 
 
FluorChem® FC2 
Roche Diagnostics Deutschland 
GmbH, Mannheim 
 
Cell Biosciences, Inc., Santa 
Clara, USA 
Electrophoresis apparatus 
(SDS-PAGE) 
Mini-PROTEAN Tetra Cell for 
Mini precast gels 
Bio-Rad Laboratories GmbH, 
München 
Electrophoresis apparatus 
(Agarose gel) 
 
Bio-Rad Laboratories GmbH, 
München 
Elisa Reader 
Multiskan EX Microplate 
Photometer 
Fisher Scientific GmbH, 
Schwerte 
Film developer Optimax X-ray Film Processor 
PROTEC GmbH & Co. KG, 
Oberstenfeld 
Ice machine Ziegra ZBE 70-35 
Ziegra Eismaschinen 
Isernhagen, Deutschland 
Inverse Microscope AE 20 
Motic Deutschland GmbH, 
Wetzlar 
Lamina flow hood for cell 
culture 
HERAsafe 
 
BIOWIZARD Silver Line 
Heraeus, Hanau 
 
Kojair Tech oy, Vilpulla, 
Finnland 
Magnetic stirrer Combimag RCT 
IKA® Werke GmbH & Co. KG, 
Staufen 
Microscope 
Observer Z1, Apotome, 
HXP120, 
Axiocam MRm 
Zeiss AG, Jena 
pH-meter Consort C864 
Consort bvba, Turnhout, 
Belgien 
Photometer Smart Spec™ 
Bio-Rad Laboratories GmbH, 
München 
PCR thermal cyclers 
GeneAmp® PCRSystem 2700 
Mastercycler gradient 
Applied Biosystems, Carlsbad, 
USA 
Eppendorf AG, Hamburg 
Power supply (blotting and 
electrophoresis) 
Power Pac HC™ 
 
Standard Power Pack 25 
Bio-Rad Laboratories GmbH, 
München 
Biometra GmbH, Göttingen 
Scanner HP Scanjet 5530 
Hewlett-Packard GmbH, 
Böblingen 
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Equipment Type Supplier 
Scales 
Scout™ Pro 
Explorer® Pro 
Ohaus, New Jersey, USA 
SDS Precast gels Mini-PROTEAN® Precast Gels 
Bio-Rad Laboratories GmbH, 
München 
Tissue Homogeniser, Dounce 432-1272 VWR International 
Table centrifuge Profuge™ 10K 
Agilent Technologies Inc., 
Santa Clara,USA 
Thermomixer Thermomixer comfort Eppendorf AG, Hamburg 
Ultra pure water system Ultra Clear 
SG Wasseraufbereitung und 
Regenerierstation GmbH, 
Barsbüttel 
Ultrasonic homogenizer Sonopuls HD 2070 
BANDELIN electronic GmbH & 
Co. KG, Berlin 
UV Transilluminator IL-200-M 
H. Saur Laborbedarf, 
Reutlingen 
Vacuum pump VP 86 
VWR International GmbH, 
Darmstadt 
Vortexer VortexGenie2 
Scientific Industries, Inc. New 
York, USA 
Water bath Schüttelwasserbad 1083 
GFL Gesellschaft für 
Labortechnik GmbH, 
Burgwedel 
Western Blot apparatus Semidry Transfercell 
Bio-Rad Laboratories GmbH, 
München 
 
2.2 Chemicals 
Material Name Supplier 
1-Isopropyl β-D-thiogalactopyranoside (IPTG) AppliChem GmbH, Darmstadt 
2-Propanol AppliChem GmbH, Darmstadt 
2xYT Carl Roth GmbH & Co.KG, Karlsruhe 
3-AT (3-Amino-1, 2, 4-triazol) Sigma-Aldrich Chemie GmbH, München 
30% Acrylamide solution with 0,8% 
Bisacrylamide 
Carl Roth GmbH & Co.KG, Karlsruhe 
β-Mercaptoethanol Sigma-Aldrich Chemie GmbH, München 
Acetic acid AppliChem GmbH, Darmstadt 
Agar AppliChem GmbH, Darmstadt 
Agarose Biozym Scientific GmbH, Hessisch Oldendorf 
Ammonium chloride (NH4Cl) AppliChem GmbH, Darmstadt 
Ammonium per(oxodi)sulfate (APS) Sigma-Aldrich Chemie GmbH, München 
Ampicillin AppliChem GmbH, Darmstadt 
BactoTM-Trypton AppliChem GmbH, Darmstadt 
Bovine serum albumin (BSA) Carl Roth GmbH & Co.KG, Karlsruhe 
Bromphenol blue Bio-Rad Laboratories GmbH, München 
Calcium chloride (CaCl2) Sigma-Aldrich Chemie GmbH, München 
Coomassie brilliant blue R-250 Sigma-Aldrich Chemie GmbH, München 
D (+) Glucose monohydrate AppliChem GmbH, Darmstadt 
D (+) Saccharose Carl Roth GmbH & Co.KG, Karlsruhe 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich Chemie GmbH, München 
Dipotassium phosphate (K2HPO4) Carl Roth GmbH & Co.KG, Karlsruhe 
Disodium hydrogen phosphate (Na2HPO4) Carl Roth GmbH & Co.KG, Karlsruhe 
Dithiothreitol (DTT) Sigma-Aldrich Chemie GmbH, München 
Ethanol Carl Roth GmbH & Co.KG, Karlsruhe 
Ethidium bromide (10mg/ml) AppliChem GmbH, Darmstadt 
Ethylendiaminetetraacetic acid (EDTA) Sigma-Aldrich Chemie GmbH, München 
Ethylene glycol tetraacetic acid (EGTA) Sigma-Aldrich Chemie GmbH, München 
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Material Name Supplier 
Formaldehyde Merck KGaA, Darmstadt 
Gelatin Carl Roth GmbH & Co.KG, Karlsruhe 
Gentamycin sulfate Merck KGaA, Darmstadt 
Glutaraldehyde solution Sigma-Aldrich Chemie GmbH, München 
Glycerin (Glycerol) AppliChem GmbH, Darmstadt 
Glycin AppliChem GmbH, Darmstadt 
Hepes Carl Roth GmbH & Co.KG, Karlsruhe 
Hydrogen chloride (HCl) 37 % Carl Roth GmbH & Co.KG, Karlsruhe 
Imidazole Carl Roth GmbH & Co.KG, Karlsruhe 
Kanamycin sulfate AppliChem GmbH, Darmstadt 
Lithium actetate AppliChem GmbH, Darmstadt 
LB-Broth Carl Roth GmbH & Co.KG, Karlsruhe 
Magnesium chloride AppliChem GmbH, Darmstadt 
Magnesium sulfate (MgSO4) Merck KGaA, Darmstadt 
Manganese chloride (MnCl2) Sigma-Aldrich Chemie GmbH, München 
Methanol Th. Geyer GmbH & Co. KG, Renningen 
Minimal SD Base 
Clontech Laboratories, Inc., Mountain View, 
USA 
Mowiol 4-88 Carl Roth GmbH & Co.KG, Karlsruhe 
N, N, N´, N´-Tetramethylendiamine (TEMED) Sigma-Aldrich Chemie GmbH, München 
Na-MOPS (3-(N-Morpholino)propanesulfonic acid)  Roche Diagnostics GmbH, Mannheim 
Nocodazole Sigma-Aldrich Chemie GmbH, München 
NP-40 (Ipegal) Sigma-Aldrich Chemie GmbH, München 
Orthophosphoric acid 85% Sigma-Aldrich Chemie GmbH, München 
Paraformaldehyde (PFA) 4% Sigma-Aldrich Chemie GmbH, München 
PEG 3350 Carl Roth GmbH & Co.KG, Karlsruhe 
Bacto™Peptone BD Biosciences, USA 
PMSF (Phenylmethylsulfonylfluorid)) AppliChem GmbH, Darmstadt 
Polybrene Sigma-Aldrich Chemie GmbH, München 
Potassium acetate (KOAc) Merck KGaA, Darmstadt 
Potassium chloride Merck KGaA, Darmstadt 
Potassium dihydrogen phosphate Sigma-Aldrich Chemie GmbH, München 
Potassium ferricyanide Carl Roth GmbH & Co.KG, Karlsruhe 
Ponceau S solution Sigma-Aldrich Chemie GmbH, München 
Puromycin dihydrochloride Sigma-Aldrich Chemie GmbH, München 
Silver nitrate (AgNO3) Carl Roth GmbH & Co.KG, Karlsruhe 
Sodium acetate Carl Roth GmbH & Co.KG, Karlsruhe 
Sodium azide Sigma-Aldrich Chemie GmbH, München 
Sodium carbonate (Na2CO3) Merck KGaA, Darmstadt 
Sodium chloride AppliChem GmbH, Darmstadt 
Sodium deoxycholate Sigma-Aldrich Chemie GmbH, München 
Sodium dihydrogen phosphate dihydrate Sigma-Aldrich Chemie GmbH, München 
Sodium dodecyl sulfate (SDS) AppliChem GmbH, Darmstadt 
Sodium fluoride (NaF) Merck KGaA, Darmstadt 
Sodium orthovanadate (Na3VO4) Sigma-Aldrich Chemie GmbH, München 
Sodium thiosulfate pentahydrate (Na2S2O3 x 
5H20) 
Carl Roth GmbH & Co.KG, Karlsruhe 
Triton® X-100 Sigma-Aldrich Chemie GmbH, München 
Tween 20 AppliChem GmbH, Darmstadt 
Yeast synthetic drop-out  BD Biosciences, USA 
Yeast extract AppliChem GmbH, Darmstadt 
2.3 Laboratory Requirements and Consumptive Materials 
Material Name Supplier 
1 kb DNA ladder Promega GmbH, Mannheim 
100bp DNA ladder Promega GmbH, Mannheim 
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Material Name Supplier 
4´, 6-Diamidin-2-phenylindol (DAPI) Invitrogen Life Technologies GmbH, Darmstadt 
6 x Loading Dye Solution Promega GmbH, Mannheim 
Bacterial culture dishes Greiner Bio-One GmbH, Frickenhausen 
Bacterial culture tubes Sarstedt AG & Co., Nümbrecht 
Blotting Paper Whatman Schleicher & Schüll GmbH, Dassen 
Calf Serum Iron Supplemented (Cs/Fe) Cell Concepts GmbH, Umkirch 
Cell/tissue culture dish/flask Becton Dickinson GmbH, Heidelberg 
Centrifuge tubes (15 ml, 50 ml) Becton Dickinson GmbH, Heidelberg 
Collagen type IV Biochrom AG, Berlin 
Cover slips Diagonal GmbH & Co. KG, Münster 
Cryo tubes Nunc A/S, Roskilde, Dänemark 
Cuvette Sarstedt AG & Co., Nümbrecht 
DMEM Invitrogen Life Technologies GmbH, Darmstadt 
dNTPs Promega GmbH, Mannheim 
Fetal Calf Serum (FCS) Biochrom AG, Berlin 
Fetal Bovine Serum (FBS) Invitrogen Life Technologies GmbH, Darmstadt 
Flexi-Strip  GEPE-BiWeX N.V., Breda, Niederlande 
Geltrex® LDEV-Free Matrix Products Invitrogen Life Technologies GmbH, Darmstadt 
Gloves Paul Hartmann AG, Heidenheim 
HEPES buffer PAA Laboratories GmbH, Cölbe 
Hering sperm Invitrogen Life Technologies GmbH, Darmstadt 
Hypodermic needles Becton Dickinson GmbH, Heidelberg 
Ibidi µ-Dish35mm, low Ibidi GmbH, Martinsried 
Lipofectamine™ 2000 Invitrogen Life Technologies GmbH, Darmstadt 
Lumi-Light/Lumi-LightPLUS Roche Diagnostics GmbH, Mannheim 
Microscope slides VWR International GmbH, Darmstadt 
Microtiter plates (96 well) Sarstedt AG & Co., Nümbrecht 
Mini-Protean® TGX™ Precast Gels (4-15%)  Bio-Rad Laboratories GmbH, München 
Normal goat serum (NGS) Dianova GmbH, Hamburg 
Oligo-dT Primer Promega GmbH, Mannheim 
Nunc Lab-Tek Chamber Slides (8 wells) Sigma-Aldrich Chemie GmbH, München 
Page Ruler™ Plus Prestained Protein ladder Thermo Scientific Inc., Waltham, USA 
Parafilm Pechiney Plastic Packaging Chicago, USA 
PBS, 1x, sterile PAA Laboratories GmbH, Cölbe 
PCR-tubes (8-well strips) Biozym Scientific GmbH, Hessisch Oldendorf 
Penicillin/Streptomycin PAA Laboratories GmbH, Cölbe 
Penicillin/Streptomycin/Glutamin 100x (PSG) PAA Laboratories GmbH, Cölbe 
Pipette tips Sarstedt AG & Co., Nümbrecht 
Protease Inhibitor complete Roche Diagnostics GmbH, Mannheim 
PVDF-Immobilon membrane (0,45 µm) Millipore GmbH, Schwalbach 
RPMI 1640 PAA Laboratories GmbH, Cölbe 
Scalpel Becton Dickinson GmbH, Heidelberg 
Safe lock tubes 0,5-2,0 ml Eppendorf, Carl Roth GmbH & Co.KG, Karlsruhe 
Sieves (polyester) Reichelt Chemietechnik, Heidelberg 
SNAP-Surface® 488 New England Biolabs GmbH, Frankfurt a.M. 
SNAP-Surface® 594 New England Biolabs GmbH, Frankfurt a.M. 
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Material Name Supplier 
Sodium pyruvate solution PAA Laboratories GmbH, Cölbe 
Sodium-Transferrin-Sodium-Selenite supplement Roche Diagnostics GmbH, Mannheim 
Sterile filter Millipore GmbH, Schwalbach 
Stripette pipets Corning B.V. Life Sciences, Amsterdam, NL 
Syringe Becton Dickinson GmbH, Heidelberg 
Trypsin EDTA (10x) PAA Laboratories GmbH, Cölbe 
Water, RNAse free AppliChem GmbH, Darmstadt 
 
2.4 Buffers and Solutions 
Buffers, solutions and media were made with ultrapure water and sterilised either 
by autoclaving (121°C, 30 minutes) or by sterile filtration (pore size: 22µm). 
Solution Name Contents 
100x L-Histidine stock solution 2g/l L-Histidine 
100x L-Leucine stock solution 10g/l L-Leucine 
100x L-Tryptophan stock solution 2g/l L-Tryptophan 
10x Amino acid solution 
200mg L-Adeninhemisulfat 
200mg L-Arginine x HCl 
300mg L-Isoleucine 
300mg L-Lysine x HCl 
200mg L-Methionine 
500mg L-Phenylalanine 
2000mg L-Threonine 
300mg L-Tyrosine 
200mg Uracil 
1500mg L-Valine 
10xPBS 
0,038M NaH2PO4 
0,162M Na2HPO4 
1,5M NaCl 
ad H2O  
pH 7,4 
1M Tris/HCl, pH von 6,8-8,8 
121.14g Tris 
ad 1l mit H2O 
adjust desired pH with HCl 
2x HEBS 
50mM HEPES 
280mM NaCl 
10mM KCl 
1,5mM Na2HPO4x H2O 
12mM Glucose 
ad H2O 
pH 7.05 
Antibody solution for IF 
98 % (v/v) IF wash buffer 
2 % (v/v) normal goat serum (NGS) 
Blocking solution for IF 
90 % (v/v) IF wash buffer 
10 % (v/v) normal goat serum (NGS) 
Coomassie solution 
0,6 % (w/v) Coomassie brilliant blue 
10 % (v/v) Acetic acid 
ad H2O 
Coomassie destaining solution 
7 % (v/v) Acetic acid 
5 % (v/v) Ethanol 
ad H2O 
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Solution Name Contents 
IP buffer 
20mM Tris-HCl (stock solution 1 M, pH 7,4) 
20mM NaCl 
1mM EDTA 
50mM NaF 
15mM Na4P2O7 
1 % (v/v) Triton X-100 
ad H2O 
LB medium  
20 g/l LB-Broth  
ad H2O  
LB agar plates 
LB-Medium  
20 g/l Agar  
Lysis buffer 
50mM Hepes (1M) 
150mM NaCl 
1.5mM MgCl2 
1mM EGTA 
10% (v/v) Glycerin 
1 % (v/v) Triton X-100 
ad H2O 
Laemmli sample buffer 
20 % (v/v) Glycerin  
125mM Tris-HCl pH 6,8 
10 % (w/v) SDS 
0,2 % (w/v) Brom phenole blue 
5 % ß-Mercaptoethanol 
ad H2O 
PCR ready made solution (Genotyping) 
50mM KCl 
10mM Tris/HCl pH 8.3 
1,5mM MgCl2 
0,45% NP-40 
0,45% Tween20 
ad H2O 
Running buffer 
25mM Tris 
0,05 % (w/v) SDS 
0,2M Glycin 
ad H2O 
SD medium  
6.7g Yeast synthetic drop-out medium 
(ad 20g/l Agar for plates) 
ad H2O to 1l and autoclave 
50ml 40% Glucose solution 
Stripping buffer 
15g Glycin 
1g SDS 
10ml Tween 20 
Adjust pH to 2,2  
ad H2O to 1l  
Supplements for cell culture 
0,5ml non essential amino acids 
0,5ml Insulin-transferrin-sodium selenite 
(10mg/ml) 
0,5ml Sodium pyruvate (100mM) 
2,5ml Hepes (1M) 
TAE buffer 
40mM Tris-HCl 
1mM EDTA-Na2 salt 
40mM Acetic acid 
ad H2O, pH 8,2 
TBS 
50mM Tris 
150mM NaCl 
ad 800ml H2O, pH 7,5 
TBST 
10mM Tris-HCl (stock solution 1 M, pH 7,4) 
150mM NaCl 
0,05 % (v/v) Tween 20 
ad 1l H2O 
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Solution Name Contents 
TfB1 medium 
10mM CaCl2 
100mM KCl 
50mM MnCl2 
30mM KOAc 
Glycerin (15 % v/v) 
ad 1l H2O and sterilize by filtration 
TfB2 medium 
10mM KCl 
75mM CaCl2 
10mM Na-MOPS, pH 7,0 
Glycerin (15 % v/v) 
ad 1l with H2O and autoclave 
Transfer buffer  
25mM Tris (1M stock solution pH 8,3) 
192mM Glycin 
20 % (v/v) Methanol 
ad H2O 
TYM medium 
2% (w/v) Bacto™ Tryptone 
0,5% (w/v) Bacto™ yeast extract 
10mM MgSO4 
100mM NaCl 
ad H2O to 1l and autoclave  
Wash buffer for IF 
10 % (v/v) 10 x PBS 
0,2 % (w/v) Gelatine 
0,2 % (v/v) Triton X-100 
ad H2O 
Yeast –L/-T/-H SD plates 
420ml SD medium 
25ml 40% Glucose 
5ml 100x L-Histidine stock solution 
50ml 10x Amino acid solution 
Yeast –L/-T SD plates 
400ml SD medium 
25ml 40% Glucose 
50ml 10x Amino acid solution 
25ml 50mM 3-AT  
YPD medium 
20g Bacto™ Peptone 
10g Yeast extract 
20g Glucose 
ad H20 to 1l and autoclave 
(ad 20g/l Agar for plates) 
2.5 Enzymes 
Name Supplier 
AccuprimeTM Pfx DNA Polymerase Invitrogen Life Technologies GmbH, Darmstadt 
Big Dye® Terminator v3.1 Cycle Sequencing Kit Invitrogen Life Technologies GmbH, Darmstadt 
DNA Polymerase I, Large Fragment New England Biolabs GmbH, Frankfurt a.M. 
Gateway® LR Clonase® enzyme mix Invitrogen Life Technologies GmbH, Darmstadt 
Go Taq DNA Polymerase Promega GmbH, Mannheim 
Lysozyme Carl Roth GmbH & Co.KG, Karlsruhe 
M-MLV Reverse Transcriptase Promega GmbH, Mannheim 
Pfu Turbo DNA Polymerase Stratagene  
PNGase F New England Biolabs GmbH, Frankfurt a.M. 
Proteinase K Qiagen GmbH, Hilden 
Restriction endonuclease, buffer and BSA New England Biolabs GmbH, Frankfurt a.M. 
RNAse A Invitrogen Life Technologies GmbH, Darmstadt 
Shrimp Alkaline Phosphatase (SAP) Promega GmbH, Mannheim 
T4 DNA Ligase and Buffer Fermentas GmbH, St. Leon-Rot 
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2.6 Antibodies 
Primary Antibody Supplier WB IF/IHC 
α-actinin-4 Enzo Life Sciences AG, Lausen 1:1000 - 
Crumbs3 
Sigma-Aldrich Chemie GmbH, 
München 
1:300 1:50 
Crumbs3a 
Prof. B. Margolis University of 
Michigan, Ann Arbor, USA 
1:500 1:100 
EEA1 BD Biosciences, USA - 1:200 
GM130 BD Biosciences, USA - 1:250 
GAPDH Covance Inc., Princeton, USA 1:2000 - 
JL-8 (GFP) 
Takara Bio Europe/Clontech, 
Japan 
1:1000 - 
LAMP2 DSHB, University of Iowa, USA - 1:100 
M2 (FLAG) 
Sigma-Aldrich Chemie GmbH, 
München 
1:5000 - 
MPP5 
Sigma-Aldrich Chemie GmbH, 
München 
1:500 1:50 
Merlin/NF2 Abcam, Milton, UK - 1:200 
Nephrin Acris Antibodies GmbH, Herford 1:500 1:50 
Podocin 
Sigma-Aldrich Chemie GmbH, 
München 
1:1200 1:50 
Rab7 
Cell Signaling Technology, Inc., 
USA 
- 1:50 
Rab8 BD Biosciences, USA - 1:50 
Rab11 BD Biosciences, USA - 1:50 
Snap New England BioLabs Inc., USA 1:500 - 
WT1 
Dako Deutschland GmbH, 
Hamburg 
- 1:200 
ZO-1 
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:250 
ß-Tubulin 
Sigma-Aldrich Chemie GmbH, 
München 
1:500 - 
 
Secondary Antibody Supplier WB IF/IHC 
Alexa Fluor® 350 conjugated  
α-Mouse IgG 
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:1000 
Alexa Fluor® 488 conjugated 
Phalloidin 
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:100 
Alexa Fluor® 488 conjugated  
α-Mouse IgG 
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:1000 
Alexa Fluor® 488 conjugated 
α-Rabbit IgG 
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:1000 
Alexa Fluor® 488 conjugated 
α-Guinea Pig IgG 
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:1000 
Alexa Fluor® 488 conjugated 
α-Goat IgG 
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:1000 
Alexa Fluor® 594 conjugated 
Phalloidin  
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:100 
Alexa Fluor® 594 conjugated 
α-Mouse IgG 
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:1000 
Alexa Fluor® 594 conjugated 
α-Rabbit IgG 
Invitrogen Life Technologies 
GmbH, Darmstadt 
- 1:1000 
Horse Radish Peroxidase (HRP) 
conjugated α-Mouse IgG 
Jackson Immunoresearch 
Laboratories, Inc., England 
1:5000 - 
Horse Radish Peroxidase (HRP) 
conjugated α-Rabbit IgG 
Jackson Immunoresearch 
Laboratories, Inc., England 
1:2500 - 
Horse Radish Peroxidase (HRP) 
conjugated α-Goat IgG 
Jackson Immunoresearch 
Laboratories, Inc., England 
1:2500 - 
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2.7 Oligonucleotides 
Primer Sequence (5´-> 3´) 
CLPI tail forward ttttaagcttcgggagaagcggcag 
CLPI tail reverse aaaaatcgatctagatgggcaggcagccctgc 
Crb3AgeIMut forward ccaccagctccagctccgacggaggtggaaccggtggaggcgatggcaacctgcgtccagaagc 
Crb3AgeIMut reverse gcttctggacgcaggttgccatcgcctccaccggttccacctccgtcggagctggagctggtgg 
mCherryAgeI forward ttttaccggtgtgagcaagggcgaggaggataacatgg 
mCherryAgeI reverse aaaaaccggtcttgtacagctcgtccatgcc 
SnapAgeI forward ttttaccggtgacaaagactgcgaaatgaagcgc 
SnapAgeI reverse aaaaaccggtcagcccaggcttgcccagtctgtgg 
3xFLAGAgeI forward 
ttttaccggtgactacaaggaccacgacggcgactacaaggaccacgacatcgactacaaggacg
acgacgacaagaccggttttt 
3xFLAGAgeI reverse 
aaaaaccggtcttgtcgtcgtcgtccttgtagtcgatgtcgtggtccttgtagtcgccgtcgtggtcctt
gtagtcaccggtaaaa 
SOE P1 Crb3 forward gcggccgcatggcgaaccccgggctggggctgc 
SOE P2 crossing Nephrin 
forward 
ggctggcactgttggtgcggaagcttaatgcctcctgtgtcgggggggtcctctgg 
SOE P3 crossing Nephrin 
reverse 
ccagaggacccccccgacacaggaggcattaagcttccgcaccaacagtgccagcc 
SOE P4 Nephrin reverse ttaattaattacaccagatgtcccctcagctcgaagg 
Pals1 forward caccgggcgcgccctcgagatgacaacatcccatatgaatgggc 
Pals1 reverse gcggccgcggatcctcacctcagccaagtggatggtaccc 
Pals1 sequencing primer gaatactccacatattcaggcacttttactggc 
rtmmCrb3 forward caagatgcggtaggaattgg 
rtmmCrb3 reverse gagtctgattgcccaaagag 
Cre forward gcattaccgtcgatgcaacgagtgatgag 
Cre reverse gagtgaacgaacctggtcgaaatcagtgcg 
Genotyping LoxP forward tttttcccacttctcattacagtg 
Genotyping LoxP reverse gccctccgtttcctcttatc 
M13 forward gtaaaacgacggccag 
M13 reverse caggaaacagctatgac 
pQCXIP forward acgccatccacgctgttttgacct 
pQCXIP reverse ggaaagacccctaggaatgc 
2.8 Commercial Kits 
Name Supplier 
DNA Clean & ConcentratorTM Zymo Research Corporation, Irvine, USA 
ZymocleanTM Gel DNA Recovery Kit Zymo Research Corporation, Irvine, USA 
pENTR/SD/D-TOPO Cloning Kit Invitrogen Life Technologies GmbH, Darmstadt 
ZyppiTM Plasmid Miniprep Kit Zymo Research Corporation, Irvine, USA 
PureLinkTM HiPure Plasmid Filter Maxiprep Kit Invitrogen Life Technologies GmbH, Darmstadt 
PureLinkTM HiPure Plasmid Filter Midiprep Kit Invitrogen Life Technologies GmbH, Darmstadt 
RNeasy Mini Kit Qiagen GmbH, Hilden 
BCA (Bicinchoninic acid) Protein Assay Kit Bio-Rad Laboratories GmbH, München 
2.9 Plasmids 
Name Description Supplier 
pENTRTM/D-TOPO Entry-Vector into the Gateway® System 
Invitrogen Life Technologies 
GmbH, Darmstadt 
pCR4TM-TOPO Sequencing vector 
Invitrogen Life Technologies 
GmbH, Darmstadt 
pENTR Crb3a CT (aa 82-
120) 
C-terminus of Crb3a as entry-vector for 
the Gateway® System 
Pavenstaedt Lab, University 
Hospital Münster 
pENTR Crb3b CT (aa 82-
123) 
C-terminus of Crb3b as entry-vector for 
the Gateway® System 
Pavenstaedt Lab, University 
Hospital Münster 
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Name Description Supplier 
pENTR Pals1 
Pals1 as entry-vector for the Gateway® 
System 
Pavenstaedt Lab, University 
Hospital Münster 
pRevTre GFP Crb3a 
GFP-tagged Crb3a in pRevTre expression 
vector  
Prof. B. Margolis University 
of Michigan, Ann Arbor, USA 
pCR4-TOPO GFP Crb3a 
GFP-tagged Crb3a in pCR4-TOPO cloning 
vector 
Pavenstaedt Lab, University 
Hospital Münster 
pCR4-TOPO GFP Crb3b 
GFP-tagged Crb3b in pCR4-TOPO cloning 
vector 
Pavenstaedt Lab, University 
Hospital Münster 
pCR4-TOPO Crb3a AgeI  
Crb3a with AgeI restriction site in pCR4-
TOPO cloning vector 
Pavenstaedt Lab, University 
Hospital Münster 
pCR4-TOPO Snap Crb3a 
SNAP-tagged Crb3a in pCR4-TOPO 
cloning vector 
Pavenstaedt Lab, University 
Hospital Münster 
pCR4-TOPO Snap Crb3b 
SNAP-tagged Crb3b in pCR4-TOPO 
cloning vector 
Pavenstaedt Lab, University 
Hospital Münster 
pQCXIP GFP Crb3a 
GFP-tagged Crb3a in pQCXIP expression 
vector 
Pavenstaedt Lab, University 
Hospital Münster 
pQCXIP GFP Crb3b 
GFP-tagged Crb3b in pQCXIP expression 
vector 
Pavenstaedt Lab, University 
Hospital Münster 
pQCXIP GFP 
fpNephrin-CT 
C-terminus of Nephrin with GFP-tagged 
N-terminus and transmembrane domain 
of Crb3 in pQCXIP expression vector 
Pavenstaedt Lab, University 
Hospital Münster 
pQCXIP Snap 
fpNephrin-CT 
C-terminus of Nephrin with SNAP-tagged 
N-terminus and transmembrane domain 
of Crb3 in pQCXIP expression vector 
Pavenstaedt Lab, University 
Hospital Münster 
pQCXIP Snap Crb3a 
SNAP-tagged Crb3a in pQCXIP 
expression vector 
Pavenstaedt Lab, University 
Hospital Münster 
pQCXIP Snap Crb3b 
SNAP-tagged Crb3b in pQCXIP 
expression vector 
Pavenstaedt Lab, University 
Hospital Münster 
pQCXIP EGFP Pals1 
GFP-tagged Pals1 in pQCXIP expression 
vector 
Pavenstaedt Lab, University 
Hospital Münster 
pQCXIP mCherry Pals1 
mCherry-tagged Pals1 in pQCXIP 
expression vector 
Pavenstaedt Lab, University 
Hospital Münster 
pDest32 Crb3a CT (aa 
82-120) 
C-terminus of Crb3a in bait vector for 
yeast two-hybrid 
Pavenstaedt Lab, University 
Hospital Münster 
pDest32 Crb3b CT (aa 
82-123) 
C-terminus of Crb3b in bait vector for 
yeast two-hybrid 
Pavenstaedt Lab, University 
Hospital Münster 
pDest32 Pals1 Pals1 in bait vector for yeast two-hybrid 
Pavenstaedt Lab, University 
Hospital Münster 
pDest22 Pals1 Pals1 in prey vector for yeast two-hybrid 
Pavenstaedt Lab, University 
Hospital Münster 
pDest22 Crb3a CT (aa 
82-120) 
C-terminus of Crb3a in prey vector for 
yeast two-hybrid 
Pavenstaedt Lab, University 
Hospital Münster 
pDest22 Crb3b CT (aa 
82-123) 
C-terminus of Crb3b in prey vector for 
yeast two-hybrid 
Pavenstaedt Lab, University 
Hospital Münster 
pDSRED FYVE domain of 
EEA1 
EEA1 FYVE domain in pDsRed expression 
vector (clontech)  
Vacratsis Lab, University of 
Windsor, Canada106 
pEGFP Rab7 Q68L GFP-tagged constitutively active Rab7 
Brand Lab, University 
Hospital Münster 
pEGFP Rab11 wt GFP-tagged Rab11 wildtype 
Brand Lab, University 
Hospital Münster 
pVSVG 
Vector for production of infectious, 
replication-incompetent retrovirus to 
target mammalian cells; expresses env-
glycoprotein of vesicular stomatitis virus 
(VSV)  
Clontech Laboratories Inc., 
Mountain View, USA 
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2.10 Bacteria and Yeast 
Species Genotype Supplier 
DH10B 
F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 
∆lacX74 recA1 endA1 araD139 ∆ (ara, leu)7697 
galU galK λ- rpsL nupG /pMON14272 / 
pMON7124 
Invitrogen Life Technologies 
GmbH, Darmstadt 
TOP10 
F-mcr A∆ (mrr-hsdRMS-mcrBC) Ф80 lacZ∆M15 ∆ 
lacX74 recA1 araD139 galU galK ∆(ara-leu)7697 
rpsL (StrR)endA1 nuG 
Invitrogen Life Technologies 
GmbH, Darmstadt 
MAV203 
MATα, leu2-3,112; trp1-901, his3∆200, ade2-101, 
cyh2R, can1R, gal4∆, gal80∆, HIS3UASGAL1::HIS3 
LYS2, GAL1::lacZ, SPAL10::URA3 
Invitrogen Life Technologies 
GmbH, Darmstadt 
 
2.11 Eukaryotic Cell Lines 
Cell 
Line 
Description Conditions Medium Reference 
AB8 
Immortalised cultured 
human podocytes 
Proliferation: 
33°C, 5% CO2 
Differentiation: 
37°C, 5% CO2 
RPMI 1640  
10% FCS 
0.8% supplements 
1% Penicilin/ 
Streptomycin 
Saleem et al. 
2002107 
K8  
Immortalised cultured 
murine podocytes 
Proliferation: 
33°C, 5% CO2 
Differentiation: 
37°C, 5% CO2 
RPMI 1640  
5% FCS 
1% Penicilin/ 
Streptomycin 
(+ 10U/ml Interferon-γ for 
proliferation) 
Mundel et al. 
1999108 
GP2-
293 
Retroviral packaging 
cell line; stable 
expression of viral gag 
and pol genes 
37°C, 5% CO2 
DMEM 
10% FCS 
1% Penicilin/ 
Streptomycin 
Clontech 
Laboratories, 
Inc., USA 
HEK 
293T 
Human embryonic 
kidney cell line 
37°C, 5% CO2 
DMEM 
10%Cs/Fe 
1% Penicilin/ 
Streptomycin 
ATCC® CRL-
1573™ 
MDCKII 
Canine distal tubule cell 
line (Madine Darby 
Canine Kidney); gift 
from B. Margolis 
University of Michigan, 
Ann Arbor USA 
37°C, 8% CO2 
DMEM (without L-
Glutamine/Pyruvate) 
10% FCS 
1%Penicilin/Streptomycin/L-
Glutamine 
ATTC® CRL-
2936TM 
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2.12 Mouse Strains 
2.12.1 Pals1 Conditional Knockout Mouse Strain 
The Pals1 conditional knock out mouse line was a kind gift from Dr. Christopher 
Walsh (Children´s Hospital Boston, USA).105  
The Pals1 cKO was generated by inserting LoxP (locus of X-over P1) sites into 
introns 2 and 3 flanking exon 3 of the Pals1 gene. Activation of the Cre recombinase 
deletes exon 3, resulting in a nonsense mutation with early truncation of Pals1. This 
truncation removes most of the known functional domains, leading to the expression of 
an only 122aa long protein, thereby producing a non-functional Pals1 protein. 
2.12.2 PodocinCre (NPHS2-cre) Mouse Strain 
The PodocinCre (PodCre) transgenic mouse line expresses Cre recombinase solely in 
podocytes, since it was placed under regulatory control of the human NPHS2 (Podocin) 
promoter.109,110 When Podocin is expressed in podocytes starting during the late capillary 
loop stage, its promoter drives the expression of the Cre recombinase.109 This mouse line 
was allocated by Prof. Dr. Tobias B. Huber (University Hospital Freiburg, Germany). 
2.12.3 Six2Cre (Six2-EGFP/cre) Mouse Strain 
The Six2Cre transgenic mouse line expresses Cre recombinase under regulatory 
control of the Six2 promoter. The expression of Six2 in the kidney starts at the early 
stages of kidney branching in a subset of metanephric mesenchyme (nephron 
progenitor). There, its expression is maintained throughout development, while in adult 
mouse kidneys no expression is detected.111–113  
2.13 Software and Internet Programs 
Program/Software Supplier 
Adobe Photoshop CS2 Adobe 
Axiovision 4.8 Zeiss 
Basic Local Alignment Search Tool (BLAST) http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Corel Draw Graphics X4 Adobe 
Chromas v1.43 Technelysium Pty Ltd. 
ExPASy SIB Bioinformatics Resource Portal http://www.expasy.org 
GraphPad Prism® 5 GraphPad Software, Inc. 
ImageJ 1.46 http://rsbweb.nih.gov/ij/index.html 
MatLab  MathWorks, Germany 
National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov/ 
NEBcutter v2.0 New England BioLabs 
Panoramic Viewer 1.15 http://www.3dhistech.com/ 
Primer3Plus 
http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi 
Vector NTI 10.3.0 Invitrogen 
Universal Protein Resource http://www.uniprot.org 
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3 Methods 
3.1 Microbiological Methods 
Microbiological techniques and methods are modified versions of those in 
“Molecular cloning: A Laboratory Manual (Fourth Edition)” by Sambrook and Russell (Cold 
Spring Harbor Laboratory Press, 2012). 
3.1.1 Chemically Competent Bacteria 
To prepare chemically competent cells 22ml of TYM medium was inoculated with a 
bacterial strain of choice (2.10) and incubated at 37°C and 180rpm. The culture was 
grown to an OD600nm of 0.5-0.6, than split into two 1l conical flasks with 100ml TYM 
medium each, grown to an OD600nm of 0.5-0.6 for 2h and again diluted to 500ml TYM 
medium and grown to an OD600nm of 0.5-0.6. The flasks were then cooled for 10min on 
ice and centrifuged for 10min at 4000xg and 4°C. After removing the supernatant the 
pellet was resuspended with 100ml of prechilled TfB1 buffer and again centrifuged for 
10min at 4000xg at 4°C. The pellet was then resuspended in 10ml of prechilled TfB2 
buffer, frozen immediately in 100µl aliquots and kept at -80°C for longer storage. 
3.1.2 Bacterial Transformation 
Chemically competent bacteria (3.1.1) were used for general cloning and 
subcloning purposes.  
To start a bacterial transformation the competent cells were thawed on ice and 
approximately 100ng of DNA (e.g. ligation reaction or plasmid DNA) were added to the 
cells. After thirty minutes of incubation on ice the competent cells were heated for 1min 
at 42°C, cooled for 5min on ice and finally after adding 250µl of LB medium incubated at 
37°C and 180rpm for 1h. The reaction was plated on agar plates with appropriate 
antibiotics and incubated overnight at 37°C. 
3.1.3 Yeast Two-Hybrid Screening 
The yeast two-hybrid system is a method used for identifying protein-protein 
interactions by testing binding between two proteins.114  
To shuttle the proteins into the desired yeast strain, one is cloned into a “bait” 
vector containing one part of a transcription factor, the DNA binding domain (DBD), while 
the other is cloned into a “prey” vector containing the other part of the transcription 
factor, the activating domain (AD). In case of interaction between the bait and prey 
proteins, the transcription factor is reconstituted and transcription of reporter genes can 
occur. An interaction leads to an activation of genes coding for histidine and 
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ß-galactosidase (lacZ) and the yeast strain is able to grow on histidine depleted plates 
(-L/-W/-H selection plates). 
Here, the interaction of Pals1 with Crb3a and Crb3b was tested. Therefore, Pals1 
and the C-termini (aa Crb3a: 82-120; Crb3b: 82-123) of Crb3 isoforms were cloned into 
the shuttle vectors pDest22 (prey) and pDest32 (bait).  
For that purpose, 25ml of YPD medium (2.4.) containing 2% glucose were 
inoculated with yeast strain MAV203 (2.10.) and incubated over night at 30°C at 
160rpm. 100ml YPD medium with 2% glucose were inoculated using the preculture until  
a OD600 of 0.2 was achieved. The culture was grown at 30°C to an OD600 of 0.8, then 
pelleted at 4000xg. The pellet was resuspended in 3ml 100mM lithium acetate and 
incubated at 30°C for 15min. The sample was then centrifuged and the pellet dissolved in 
a freshly set up transformation mixture. The vector DNA was combined with the yeast-
transformation mixture, incubated for 30min at 30°C, then heat shocked at 42°C for 
30min before centrifugation. The resulting pellet was resuspended in H20 and plated on 
-L/-W (without leucin, tryptophan) and –L/-W/-H (without leucin, tryptophan, histidine) 
synthetic dropout (SD) selection plates. The plates were incubated for 5-10 days until 
growth could be detected. Colonies on –L/-W/-H plates proved an interaction between 
the two tested proteins.  
The transformation mix was set up as follows: 
   
Component Volume 
PEG 3350 (50%) 2.4ml 
LiAc solution (1M) 0.36ml 
Carrier DNA 
(herring sperm DNA) 
0.05ml 
H2O 0.69ml 
 
3.2 Molecular Cloning Methods 
Techniques and methods for molecular cloning are modified versions of those in 
“Molecular cloning: A Laboratory Manual (Fourth Edition)” by Sambrook and Russell (Cold 
Spring Harbor Laboratory Press, 2012) and “Molecular Biology and Genomics” by 
Mulhardt (Spektrum Akademischer Verlag, 2008). 
Most of the genes such as Pals1 were amplified from a podocyte DNA library and 
inserted into a pENTRTM/D-TOPO cloning vector. For further cloning steps, it was required 
to incorporate restriction sites into the utilized oligonucleotides, e.g. for subcloning into 
the pQCXIP vector the restriction sites NotI and PacI were needed.  
Crb3a was amplified from a pRevTre GFPCrb3a construct (a gift from Prof. B. 
Margolis University of Michigan, USA)115 and subcloned into the pCR4-TOPO vector. The 
pRevTre GFPCrb3a has a GFP tag in the extracellular domain, which does not interfere 
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Typically, a PCR reaction starts
melt the double-stranded DNA yielding single
denaturation step was repeated at every cycle for 30 seconds. For the 
oligonucleotides to the single
50-65°C for 30 seconds. The annealing temperature depends
of the chosen primers. Depending on the
complementary DNA strand 
polymerase/Pfu Turbo). The cycle of denaturation, annealing and elongation was 
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3.2.1.1 Splicing by Overhang Extension 
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3.2.1.2 DNA Amplification from Podocyte Genomic Library by PCR 
A cDNA library derived from a human differentiated podocyte cell line118 was 
utilised for amplification of de novo gene targets. Instead of the usually employed Taq 
polymerase, the Pfx polymerase with an additional proofreading activity was used to 
achieve an amplification of the targeted gene with high specificity, fidelity, and yield. The 
reaction and cycle program for a de novo gene amplification was set up as follows. Prior 
to use, the cDNA library was prediluted 1:100 and the oligonucleotides 1:10 (stock 
solution 100µM). 
 
Component Volume 
cDNA (1:100) 2µl 
Primer fwd (1:10) 2µl 
Primer rev (1:10) 2µl 
Buffer (10x) 5µl 
AccuprimeTM Pfx 0.4µl 
H2O 38.6µl 
 
Temperature Time 
95°C 2 min 
95°C 15 sec 
60°C 30 sec 
68°C 1 min 
68°C 10 min 
 
3.2.2 Agarose Gel Electrophoresis 
Agarose gel electrophoresis is used to analyse PCR amplified samples and 
restriction digests. The smaller the estimated fragments (<500bp) are, the higher (up to 
2%) the deployed agarose gel concentration has to be. The separation of DNA fragments 
was achieved by applying a voltage of 80-100V for 2h to the gel. Due to the negative 
charge of the sugar-phosphate backbone, the DNA fragments migrated in the agarose gel 
toward the anode. Hence, the separation of different sized DNA fragments occurred. 
Addition of ethidium bromide visualised the DNA fragments in the agarose gel. Fragment 
size determination was accomplished by comparison to a DNA marker. 
3.2.3 DNA Fragment Purification 
DNA fragments separated on an agarose gel were excised with a sterile scalpel 
and purified with the ZymocleanTM Gel DNA Recovery Kit (2.8). The isolated and purified 
DNA fragments were then used for subsequent ligation reactions. 
 
35x 
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3.2.4 Restriction Digest 
Restriction endonucleases were used to cut DNA at specific recognition sequences, 
the so-called restriction sites. Restriction digests were set up with up to 2µg of DNA, the 
required restriction enzymes and suitable buffers in a total volume of 20µl. The reaction 
was incubated at 37°C for 1-2h and was then run on an agarose gel to analyse the 
generated DNA fragments. 
3.2.5 DNA Ligation 
DNA ligation was used as a procedure of joining together two DNA molecules by 
creating a phosphodiester bond between the two fragments, e.g. a ligation of an isolated 
cDNA fragment into a plasmid. This reaction was catalysed by a T4 DNA ligase. In order 
to achieve an optimal reaction setup, the DNA components were used equimolar.  
The reaction was set up as follows. 
 
Component Volume 
Vector DNA 1µl 
Insert DNA 1-4µl 
T4 buffer 2µl 
T4 DNA ligase 2µl 
H2O ad 20µl 
 
To improve the efficiency of this reaction, the shrimp alkaline phosphatase (SAP) 
was used prior to the ligation reaction. The vector was incubated with SAP according to 
the protocol of the supplier. This step led to a dephosphorylation of the vector thereby 
preventing it from ligating without the insert and keeping it linear for the actual ligation 
reaction. The ligation reaction was incubated at room temperature for 15 minutes and 
was then ready for bacterial transformation. 
3.2.6 Isolation of Plasmid DNA 
Plasmid DNA was isolated from liquid medium cultures, which were inoculated with 
a single bacterial colony picked from an agar plate for Minipreparations with ZyppiTM 
Plasmid Miniprep Kit. For Maxipreparations with PureLinkTM HiPure Plasmid Filter Maxiprep 
Kit 500ml of liquid medium were inoculated with 500µl of precultured liquid bacterial 
culture. In both cases the liquid cultures contained appropriate antibiotics and were 
incubated at 37°C at 180rpm overnight. Isolation and purification of plasmid DNA was 
performed following standard protocols of used commercial kits (2.8). Isolated plasmid 
DNA was then cut with restriction enzymes and run on a 1-2% agarose gel to verify the 
DNA purity and the size of the fragments.  
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3.2.7 Determination of Nucleic Acid Concentration 
The concentration and purity of a DNA or RNA solution was determined measuring 
the intensity of absorbance with a spectrophotometer. At a wavelength of 260nm, the 
measured absorbance (optical density “OD”) for double-stranded DNA with a 
concentration of 50µg/ml is 1 (E260 = 1) as well as for RNA with a concentration of 
40µg/ml. To further ascertain the purity of a DNA or RNA solution, the ratio of the 
absorbance at 260nm and 280nm was calculated. A pure sample of DNA has a ratio of 
1.8 and a pure RNA sample a ratio of 2, while protein contaminated solutions have a 
lower ratio. 
3.2.8 DNA Sequencing 
In order to verify correct clones, plasmid DNA was sequenced with the chain-
termination method by Sanger et al.119 at the University Hospital Muenster. The resulting 
sequence was reviewed and analysed with the use of different software programs as 
Chromas and VectorNTI (2.11.). 
The reaction and the cycling program were set up as follows. 
 
Component Volume 
DNA template (~500ng) x µl 
Primer (10µM) 1µl 
BigDye buffer 2µl 
BigDye 3.1 mix 1µl 
H2O ad 10µl 
 
Temperature Time 
95°C 2 min 
95°C 15 sec 
50°C 15 sec 
60°C 4 min 
 
3.2.9 Extraction and Purification of RNA  
Extraction of RNA from different tissues or cell lines is a common method to detect 
RNA expression levels of genes of interest. For that purpose, RNA is extracted and 
transcribed into complementary DNA (cDNA), which is then used for specific PCR´s. 
The first step was the disruption and homogenisation of animal tissue and cells. 
Mouse tissue (eye, kidney) was shredded with the help of sterile mortar and pestle, 
following homogenisation with the QIAshredder provided in the RNeasy Mini Kit, while 
cells and primary isolated cells were grown on 10cmØ and 6cmØ cell culture dishes, 
respectively, and lysed with RNeasy RLT Buffer following homogenisation with the 
30x 
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QIAshredder. RNA was then extracted and purified following standard protocols of 
RNeasy Mini Kit (see 2.8). 
Amount and purity of extracted RNA was determined by measuring the 
absorbance at 260nm (see 3.2.7. for further details). Extracted RNA was then stored at 
— 80°C. 
3.2.9.1 Reverse Transcription PCR 
The extracted RNA was incubated with Oligo(dT) primers and RNAse free water at 
70°C for 5min. After an incubation for 10min on ice M-MLV buffer, M-MLV reverse 
transcriptase and dNTP´s were added to the first reaction setup and the mixture was 
incubated at 40°C for 1h. The complementary DNA was stored at -20°C. 
The first reaction was set up as follows: 
 
Component Volume 
RNA (~2µg) xµl 
Oligo(dT) [500µg/ml] 2µl 
M-MLV enzyme 1µl 
RNAse free H2O ad 14µl 
 
The second reaction was set up as follows: 
Component Volume 
RNA mix 14µl 
M-MLV buffer (5x) 5µl 
M-MLV enzyme 1µl 
dNTP´s 1.25µl 
RNAse free H2O ad 25µl 
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3.3 Cellbiological Methods 
3.3.1 Cell Culture 
The cell lines, growth conditions and respective media used in this work are listed 
in table 2.11. The cells were grown in 10cmØ cell culture dishes until they reached a 
density of 80-90%. Meanwhile they were fed 2-3 times a week. For passaging, the cells 
were washed with 1xPBS, detached with 500µl of 10xTrypsin/EDTA for 5-10min at 37°C 
and plated with the desired cell density into a new dish. 
To preserve the cell lines while not in use, approximately 1x107 cells were 
detached, washed with 1xPBS and centrifuged at 1000xg for 5min. The pellet was then 
resuspended in a mixture of 90% Medium and 10% DMSO. This cell suspension was 
frozen overnight at -20°C, incubated at -80°C for a few hours and then kept in liquid 
nitrogen for longer storage.  
Rapid thawing of frozen cells was accomplished at 37°C in a water bath to 
maintain viability. The thawed cell suspension was centrifuged at 1000xg for 5min, the 
cell pellet resuspended in fresh medium and seeded on a 10cm Ø cell culture dish. 
3.3.2 Transfection 
Transfection is a process of deliberately inserting plasmid DNA into cells, 
particularly eukaryotic cells. The most common methods to transfect eukaryotic cells are 
done with calcium phosphate or cationic lipids (lipofection).  
Transfection of HEK293 and GP2-293 cells occurred by means of calcium 
phosphate. The cells were grown to a density of 50% prior to transfection. After mixing 
10µg of DNA thoroughly with 250µl 2xHEBS buffer, 250µl of 0.25M CaCl2 solution was 
added dropwise to the mixture. The DNA/Ca2PO4 mixture was incubated for 20min at 
room temperature, and then added to the cells with fresh medium. The mix of negatively 
charged phosphate ions with positively charged calcium ions produced a precipitate 
binding the DNA. For the endocytosis of the precipitate, they were incubated for 8-10h. 
Subsequently, the medium was changed and the cells were incubated for another 24-48h 
prior to use for further purposes. 
Transfection of AB8 cells was performed with LipofectamineTM 2000 following the 
supplier´s standard protocols.  
3.3.3 Retroviral Gene Delivery 
Retroviral gene delivery is a common technique to stably overexpress a gene of 
interest. Here, Clontech´s Retro-XTM System was utilised for retroviral gene delivery. This 
system is based on producing a retrovirus in a modified HEK cell line (GP2-293), which 
has retroviral genes for transcription and the viral core (gag and pol) already inserted in 
its genome.  
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Via calcium phosphate transfection (3.3.2.) 5µg vector with the gene of interest as 
well as 5µg of a vector for producing the enveloping gene env (pVSV-G) were 
co-transfected into the 50-70% confluent HEK GP2-293 cells. After 72h the retrovirus 
supernatant with the gene of interest was used to infect AB8 or MDCK cells. For that 
purpose, the virus was filtered (0.45µm) and applied to AB8 or MDCK cells plated on 
6wells with equal amounts of fresh medium and virus medium. For an increased infection 
rate 8µg/ml polybrene was applied. Incubation with the virus as well as following 
convalescence with fresh medium took 24h each. Infection and convalescence cycle were 
repeated once to increase the yield of infected cells. After two cycles of infection and 
convalescence the gene of interest was stably inserted into the genome of the cell line.  
Although the infection rate is high, a lot of cells are not infected and cannot be 
used in further experiments. Therefore, to obtain a stable cell line with few wildtype cells, 
the stably transduced cell lines were treated with puromycin (2µg/ml for AB8; 5µg/ml for 
MDCK) to kill the non-infected cells, while the virus infected cells obtained a puromycin-
resistance through the utilised vector system.  
The cells had to be handled under S2 conditions. After two passages, the cells 
were handled under S1 conditions again and therefore could be used for microscopy and 
other purposes. 
3.3.4 Cell Lysate Preparation 
For cell lysate preparations two 10cmØ cell culture dishes were used for each 
approach to receive sufficient protein concentrations. After washing the cells with PBS, 
the first dish was incubated with 500µl of lysis buffer for 5min on ice; the cells were 
scraped off and applied to the second dish for the same procedure. The cell solution was 
then incubated in a reaction tube on ice, vortexed and aspirated through a syringe 15 
times every ten minutes for 1h. Subsequently, the lysate was centrifuged for 1h at 
18.000xg and 4°C. The pellet was discarded and the supernatant used for further 
experiments or stored at -20°C. 
3.3.5 Glomeruli and Primary Cell Isolation 
To isolate glomeruli from whole mouse kidneys, the kidney was explanted as 
described in 3.6.2.. The cortex was then separated from the medulla and cut into small 
pieces. The small pieces of medulla were carefully grinded through different sieves with 
decreasing pore sizes (150µm, 70µm, 30µm), while washed with PBS. The glomeruli 
remained in the 30µm-sieve, were rinsed with PBS and put into falcon tubes for further 
use. 
 In case the isolated glomeruli were not used for RNA extraction, they were 
utilised for isolating primary podocytes. For that purpose, the glomeruli were centrifuged 
at 2000rpm at 4°C for 20min, the supernatant discarded, the glomeruli resuspended in 
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medium and cultivated for 10 days at 
of the glomeruli and were detached with 
separate the podocytes from the remaining glomeruli and plated in
dishes for cultivation and subsequently for RNA extraction.
3.3.6 Analysing the Distribution
In order to analyse and compare different cell lines with varying overexpressed 
genes as well as cell lines co
quantification were established. 
The occurrence of junction formation in AB8 cells overe
Crb3b or fpNephrin-CT was quantified as follows:
area to an adjacent cell was 
Axiovision 4.8 software.  
Since cells overexpressing 
borders and could be easily measured 
clear cell borders. Therefore, WGA was used to visualise 
Approximately 20 cells per cell line were measured.
Figure 9: Analysing the junction
podocytes. GFP control cells (upper panel) were stained with WGA (red) to highlight cell borders. 
Overlapping areas of control cells as well as GFP Crb3 isoforms (
AxioVision in size and length. Scale: 20µm.
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For analysing the localisation of Pals1 in AB8 cells when co
Crb3a or Crb3b, every cell was
at the plasma membrane (Fig.
(yellow box). Approximately 100 cells per 
For analysing the distribution of Crb3a and Crb3b in AB8 cells co
isoforms, every cell was evaluated according to whether the isoform was l
plasma membrane or not (Fig.
Crb3b plasma membrane positive and Crb3a negative, while cell n
Crb3a and Crb3b plasma membrane positive.
analysis. 
Figure 10: Comparing the distribution
cultured podocytes. (A) Localisation of GFP
red) was evaluated according to whether or not Pals1 was localised at the 
plasma membrane (blue window) or in vesicles (yellow window). (B) 
cells co-expressing both Crb3 isoforms was evaluated due to thei
Crb3b was counted as localised at the plasma membrane for cell 1 and cell 2, while Crb3a was counted as 
localised the plasma membrane only for cell 2.
_______________
-expres
 evaluated according to whether or not Pals1 was localised 
 10, A; blue box), the cytoplasm (red box
stable cell line were used for quantification.
10, B). For example, cell no. 1 in Fig. 10
o.
 About 50 cells were counted
 of overexpressed Pals1 and 
-Pals1 in AB8 cells co-expressing one Snap
cytoplasm
Distribution of Crb3a and Crb3b in AB8 
r localisation at the plasma membrane. GFP 
 Scale: 20µm. 
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3.4 Protein Biochemical Methods 
3.4.1 Determination of Protein Concentration 
In order to assess the total level of protein in a solution the Pierce BCATM 
(Bicinchoninic acid) Protein Assay Kit was used. In presence of proteins the applied BCA 
Kit solutions turn purple and the absorption at 540nm is directly proportional to the 
protein concentration of the solution. Protein concentrations were determined with 
reference to a standard curve, which was done with six dilutions of known concentration 
of Bovine serum albumin (BSA).  
3.4.2 SDS Polyacrylamide Gel Electrophoresis (SDS PAGE) 
SDS polyacrylamid gel electrophoresis is a method used to separate proteins 
according to their size120. The samples to be analysed were mixed with 4xLaemmli buffer 
(containing SDS) and heated to 95°C for 5min, to denature secondary and tertiary 
protein structures and to charge the proteins negatively in proportion to their mass. The 
labelled protein samples were then loaded on precasted 4-15% gradient acrylamide gels 
(see 2.3) and run at 180V for 1h. Subsequently, the gel was ready for a immunoblot or 
Coomassie staining. 
3.4.3 Coomassie Staining 
To visualise all proteins separated on a SDS gel, the gel was stained with 
Coomassie Brilliant Blue solution for 30min on a shaker. Removing excessive Coomassie 
dye, the gel was incubated several times with coomassie destaining solution (2.4). 
3.4.4 Immunoblot 
The immunoblot or western blot is an analytical method for detecting specific 
proteins via antibody binding. Here, the semi-dry blotting method was used. 
To make the proteins accessible to the antibodies, the separated proteins in the 
SDS polyacrylamid gel were transferred onto a polyvinylidenfluoride (PVDF) membrane, 
which was activated beforehand for 1min in 100% methanol. The gel together with the 
PVDF membrane were placed in an electroblotting device with buffer soaked whatman 
filter paper. Applying 70mA per blot for 1-1.5h led to a transfer of the proteins onto the 
PVDF membrane.  
To prevent a non-specific binding of antibodies to unoccupied areas of the PVDF 
membrane, it was placed in blocking solution (5% milk powder solution) for 1h. Then, 
the membrane was incubated with an antibody specific for the protein of interest for 1h 
at room temperature or over night at 4°C. After washing the membrane several times in 
TBST (see 2.4.), the secondary antibody was applied for 30min at room temperature and 
again the membrane was washed several times before it was incubated with Lumi-Light 
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for visualising the protein-antibody binding through processing the horseradish 
peroxidase attached to the secondary antibody. The reaction output produces 
luminescence which can be detected via x-ray radiography.  
3.5 Immunofluorescence Staining and Microscopy 
Expression, localisation and dynamics of proteins were observed and analysed by 
microscopy. Thus, cells and tissue sections were labelled with specific antibodies after 
fixation or cells were transfected/transduced (retroviral) with tagged recombinant 
proteins. The cell lines mainly used for microscopy were AB8 and MDCK. 
3.5.1 Human and Murine Kidney Tissue Sections 
Sample preparation for immunohistochemical stainings of kidney sections is 
critical to maintain tissue morphology as well as antigenicity of epitopes. Therefore, it 
requires proper tissue treatment.  
After explanting the kidney tissue, it was fixed with 4% PFA (paraformaldehyde) 
for 30min, then washed three times with PBS and embedded in Tissue-Tek®. The tissue 
was sectioned with a cryostat into slices at a range of 4-5µm and mounted on a slide. 
The slides were fixated with acetone at -20°C for 10min, before washing three times with 
PBS and treatment with 0.1%Triton-X for 10min at room temperature. Afterwards, the 
slides were treated with blocking solution (5% BSA) for 1h and the first antibody solution 
(1% BSA) was applied overnight at 4° or room temperature, depending on the antibody. 
After washing with PBS, the slides were incubated with the secondary antibody solution 
(1% BSA) for 45 min at room temperature. After repeated washing the nuclei were 
stained for 5min with DAPI. The slides were then embedded in mowiol for microscopy. 
3.5.2 Electron Microscopy and Semi-Thin Cross Sections 
Electron microscopy analysis and semi-thin cross sections of Pals1wt/fl Six2Cre+ and 
Pals1wt/fl Six2Cre- control mice were done by W. Kriz, University of Heidelberg. 
3.5.3 Cell Culture  
For life cell imaging AB8 cells were either plated and grown for 24-48h in Ibidi 
dishes at 33°C, and then stained with appropriate dyes or cells were plated on cover 
slips, transfected with desired constructs and then put upside-down in an Ibidi dish for 
imaging.  
For imaging of fixed cells, cells were plated cover slips and grown to a density of 
80%, washed once with PBS and then fixated with 4% PFA for 20min on ice. After 
washing the cover slips three times with PBS, they were quenched for 10min with a 
50mM NH4Cl solution, then washed again three times with PBS, before permeabilisation 
with 0.2% Triton X-100 for 5min. After repeated washing with PBS, the cells were first 
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incubated in blocking solution for 20min, then with the primary antibody for 1h at room 
temperature. Following an extensive washing step, the cover slips were incubated with 
the secondary antibody and DAPI (if desired) for 30min. The cover slips were mounted 
on slides and embedded in mowiol for microscopy. 
3.5.4 Cyst Formation Assay 
70-80% confluent MDCKII cells were detached with cell dissociation buffer, cell 
density counted and washed with PBS. The cell pellet was resuspended thoroughly to 
obtain a single cell suspension and a calculated volume of PBS was added to achieve a 
concentration of 1x106 cells/ml. Depending on the desired cell density (10000 to 20000 
cells) the cells were diluted with 2% Geltrex solution. Meanwhile the 8-well chamber 
slides were coated with 100% Geltrex and incubated at 37°C for 30 minutes. 
Subsequently, the diluted MDCKII cells were applied to the 8-well chambers and 
incubated for at least 5 days at 37°C and 8% CO2. The medium was changed every 
second day. Here, after approximately 5 days of incubation the cysts were fixed with 4% 
PFA for 1h, washed twice with PBS before permeabilisation with 0.1% TX-100 for 20min. 
Washing with PBS was followed by blocking in PBS/G (PBS containing 2% normal goat 
serum) for 1h, then incubation with desired primary antibodies for 24h at 4°C. The 
following day, the cysts were washed 3-4 times for 30min each in PBS/G, before applying 
the secondary antibody for 24h at 4°C. If desired, DAPI (1:5000) and phalloidin (1:200) 
were added to the secondary antibody mixture. Washing with PBS/G 3-4 times for 30min 
each removed redundant antibody remains and the cysts were ready for microscopy. 
3.5.4.1 Cyst Size Quantification Analysis 
The cyst and lumen sizes of MDCK cell lines overexpressing GFP-Crb3a, 
GFP-Crb3b and GFP-fpNephrin-CT, respectively, were determined with AxioVision 4.8. 
software (Fig.11). Cysts were grown for 5 days before fixation and staining. For each cell 
line approximately 50 cysts were measured. 
 
 
 ________________________________
 
Figure 11: MDCK cyst measurement.
formation assay, cysts were grown for 5 days before fixation and staining
Cysts were then microscoped and measured with AxioVision software. The size was determined by measuring 
from basal membrane to basal membrane. 
3.6 Mouse Experiments
In this work, three different mouse strains were used: Pals
PodocinCre and Six2Cre mouse strains (see 2.12.). All thre
the central animal housing (ZTE
were kept in individual ventilated cages (IVC) with a m
For breeding purposes, two females (age: 4
(age: 5 weeks to 18 months). The littermates were genotyped 
DNA extraction from tail biopsies (3.6.1.). After 4
from their mother and put in different cages, male and female apart
3.6.1 DNA Isolation and Genotyping
For DNA isolation and genotyping, approximately 2mm of tail were cut off with a 
sterile scissor and incubated at 55°C overnight with 
proteinase K. The proteinase K was inactivated by incubation at 95°C for 10min. The 
sample was centrifuged and the DNA containing supernatant was used for genotyping.
Genotyping PCR for Cre 
 
 
_______________
 
 For measurement and quantification of cysts grown in the cyst 
 (DAPI in blue; phalloidin in red). 
Scale: 20µm. 
 
1 conditional Knockout, 
e strains were held and bred 
) at the University Hospital Muenster (UKM). The mice 
aximum of six mice in each cage
-40 weeks) were mated with one male 
after 2
-5 weeks littermates were separated 
 from each other
 
PCR ready made solution
recombinase (450bp) was set up as follows:
Component Volume 
DNA 1µl 
Cre fwd (100µM) 0.5µl 
Cre rev (100µM) 0.5µl 
DMSO (1M) 2µl 
dNTP mix (10mM) 1µl 
5x PCR buffer 10µl 
Taq polymerase 1µl 
H2O 34µl 
 Methods 
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at 
.  
-4weeks through 
.  
 (2.4.) and 
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Temperature Time 
95°C 2 min 
95°C 30 sec 
52°C 30 sec 
72°C 30 sec 
72°C 10min 
 
Genotyping PCR for Pals1 floxed mice (240bp floxed Pals1; 190bp wildtype Pals1) 
was set up as follows: 
 
Component Volume 
DNA 2µl 
loxP fwd (100µM) 0.5µl 
loxP rev (100µM) 0.5µl 
dNTP mix (10mM) 1µl 
5x PCR buffer 10µl 
Taq polymerase 1µl 
H2O 35µl 
 
 
Temperature Time 
94°C 2 min 
94°C 30 sec 
55°C 30 sec 
72°C 30 sec 
72°C 10min 
 
3.6.2 Mouse Kidney Explants 
For kidney explants the mice were anaesthetised with isofuran, killed by breaking 
their necks with a scissor and the kidneys retrieved. After removing the renal capsule, 
the kidneys were immediately put into 4% PFA at room temperature for fixation.  
3.6.3 Analysis of Pals1 cKO Phenotype 
In order to analyse the phenotype of Pals1wt/fl Six2Cre+ knockout and compare it to 
Pals1wt/fl phenotype, diverse aspects of analysis and methods of quantification were 
established: the number of glomeruli per kidney section, size of glomeruli as well as 
distance of visceral to parietal epithelial cells in the glomerulus per kidney section, size 
and number of cysts per kidney section. Kidneys of six littermates (3 Cre– and 3 Cre+) 
and one section of each kidney were used for quantification purposes.  
30x 
40x 
 ________________________________
 
The number of glomeruli 
section (whole slides). The size of glomeruli as well as the di
parietal cells were measured with the software program panoramic viewer (2.13.) as 
shown in figure 12, A. The total amount of cysts counted per kidney section
into account.  
To determine the size of cysts per kidney sec
and measured as area of a cir
viewer, the radius was then calculated as well as the expanse of the cyst
We determined cysts as epithelium lined fluid filled cavities bigger than 
approximately 35µm in diameter and 1000
 
Figure 12: Example of measurement
sections of Pals1fl/wt Six2Cre+ litter mates (n=3)
opposite parietal podocytes. Distance between visceral to parietal cells
capillary loop to parietal cells of the Bowman´s capsule.
determined by measuring the diameter and calculating the ci
  
_______________
represents the total amount of glomeruli seen per kidney 
stance between visceral to 
tion, the cysts were treated as circles 
cle (A = πr2). The diameter was measured with panoramic 
µm2 in expanse. 
 and quantification of kidney sections.
 (A) Size of glomeruli were measured from 
 was measured from podocytes in the 
 (B) For simpler quantification cyst expanse was 
rcle area (A = πr2).  
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 was taken 
 (Fig.12, B).  
 
 (A,B) Kidney 
vascular pole to 
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4 Results 
The podocyte is of major importance for a functional filtering action of the 
glomerular capillary wall. The podocyte´s loss of cell polarity, a key feature of all 
glomerular diseases, is accompanied by the loss of slit diaphragm function consequently 
resulting in proteinuria and a nephrotic syndrome. Therefore, it is of undeniable 
importance to take a closer look at the underlying mechanisms of establishment and 
maintenance of cell polarity, in order to devise strategies for podocyte repair and 
consequently restoring renal filtration function.10,94,121 
Due to the huge apical domain of podocytes, it was the aim of this work to 
investigate which role the apical Crumbs complex, more precisely Crb3 and Pals1, play in 
establishing the podocyte´s apical domain, how an imbalance in their expression might 
affect the podocyte´s polarity and in how far the Crumbs complex is connected to slit 
diaphragm proteins. 
 
4.1 Crumbs Complex Members are Highly Expressed in 
Podocytes 
4.1.1 Expression and Localisation of Crb3 and Pals1 in Murine and 
Human Kidney Sections 
In order to investigate the Crumbs complex in podocytes, the first step was to see 
if and where Crb3 and Pals1 are expressed in glomerular podocytes. To approach this 
question, murine kidney sections were stained with antibodies against Pals1 and Crb3 
(Fig.13). The co-staining of Nephrin with Crb3 and Pals1, respectively, shows a 
co-localisation of Crb3 as well as Pals1 with Nephrin in glomerular podocytes (Fig.13, 
magnified images).  
 
 ________________________________
 
Figure 13: Co-localisation of 
kidney sections. Staining of endogenous 
antibody (Sigma) is directed against the FERM domain, so that a staining of both 
occurred. For detection of podocytes an antibody against Nephrin was used. Nephrin staini
middle and merge of both is shown on the right side. Areas with co
shown magnified in small boxes on the far right. Nuclei staining with DAPI in blue. Scale: 20µm.
Additionally, immunofluoresce
expression of Pals1 and Crb3 in glomeruli as well as an co
podocyte specific marker WT
antibodies against Crb3 were utilised. O
in staining of murine kidney sections and detected both 
antibody (gift from B. Margolis) 
C-terminal ERLI domain.  
________________
Crb3 and Pals1 with podocyte marker Nephrin in murine 
Crb3 and Pals1 are shown on the left side. The applied 
Crb3 isoforms (3a and 3b) 
-localisation of Crb3/Pals1 with Nephrin are 
nce staining of human kidney sections showed 
-localisation of 
-1 (Wilms tumour protein; Fig.14). Here, two different 
ne antibody (Crb3 Sigma) was the same as used 
Crb3 isoforms, while the second 
was directed against Crb3a specifically, targeting the 
 Results 
44 
 
Crb3 
ng is shown in the 
 
Crb3 with the 
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Figure 14: Co-localisation of 
sections. Staining of endogenous 
exhibits staining with an antibody against both Crb3 isof
human glomerulus is illustrated. Areas of co
boxes on the far right. Scale: 20µm.
Taken together, it can be said, that there is a strong ex
murine and human glomeruli. A closer look, even reveals a co
the area of the slit diaphragm of the podocytes.  
4.1.2 Expression of Crb3
To further affirm the expression of 
were conducted. For that purpose, immortalised murine podocytes (K8) as well as 
primary isolated murine podocytes and glomeruli were used. K8 cells were grown on 
10cmØ dishes until they reached a 
Three independent mRNA extractions were made of K8 cell lines (K8
Glomeruli and primary podocytes were extracted from whole mouse kidneys
described in 3.3.5 and RNA was purified as explained in 3.2.9
utilised for PCR´s run with primers specific for Crb1 and 
________________
Crb3 with podocyte marker WT-1 in human kidney 
Crb3a in glomeruli with WT-1 is shown in the first row. The second row 
orms with WT-1. At the bottom Pals1 staining of a 
-localisation of Crb3 with WT-1 are demonstrated magnified in small 
 
pression of Crb3 and Pals1 
-localisation with Nephrin in 
 
 on mRNA Level 
Crb3 in glomerular podocytes, mRNA analysis 
confluency of 80%, and the mRNA was
. The obtained cDNA was 
Crb3.  
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 extracted. 
-1, K8-2, K8-3). 
, as 
 ________________________________
 
Figure 15: PCR analysis of mRNA expression levels for Crumbs.
comprised of four exons. Crb3b, a splice form of Crb3
exon of the Crb3 gene, leading to a 
were chosen in a manner that both isoforms would be detected (red arrows)
Crb3a/3b (lower gel) specific PCR´s on immortalised murine podocytes (K8
podocyte (P-1 and P2) and murine glomeruli (Gloms)
estimated size of 300bp. The PCR analy
890bp for immortalised murine podocytes (K81
estimated size of 480bp for immortalised murine podocytes (K81
as for glomeruli (Gloms). Asterisks mark unspecific PCR fragments.
In case of Crb3, the primers were chosen in a manner that both isoforms 
detected differing only in the size of the bands
signals for Crb1 in either sample, while the PCR analysis for 
Crb3a at approximately 800bp and for Crb3b at 480bp, as anticipated. Crb3a is 
expressed in immortalised murine podocytes as well as in murine glomeruli. Crb3b shows 
an even stronger expression for all three approaches. Freshly extracted glomeruli seem 
to have the highest expression level
In case of Pals1, high expression in glomeruli and 
was shown via mRNA profiling and analysis.
cooperation with C. Cohen, University of Zuerich
4.2 Analysis of Ectopic Crb3 and fpNephrin
Cells 
Imunofluorescence analysis of murine and human kidney sections as well as 
mRNA expression analysis prove that 
glomerular podocytes. There is a
and Crb3b (Fig.15), suggesting Crb3b to be more important in podocytes than Crb3a. 
To approach these aspects as well as the possible connection to slit diaphragm 
proteins, different constructs of Crb
established. 
________________
 (A) 
a, is generated by alternate splicing within the fourth 
shorter mRNA and finally a different C-terminus. Primer for PCR analysis 
. (B) Crumbs1 (upper gel) and 
-1 to K8-3), primary isolated murine 
. The PCR anaylsis for Crb1 show
sis for Crb3a and 3b exhibits bands for Crb3a at the estimated size of 
-3) as well as for glomeruli (Gloms) and bands for Crb3b at an 
-3), primary isolated podocytes (P1
 
 (Fig. 15, A). Figure 15, B
Crb3 exhibits bands for 
, especially for Crb3b.  
immortalised human 
118,122 The mRNA profiling was done in 
. 
-CT in Renal Epithelial 
Crb3 as well as Pals1 are highly expressed in 
lso a difference in expression pattern
3 isoforms, Pals1 and fpNephrin
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The Crb3 gene is 
s no bands at the 
-2) as well 
would be 
 shows clearly no 
podocytes 
s between Crb3a 
 
-CT (Fig.8) were 
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4.2.1 Cell Line Generation for Ectopic 
Expression 
Figure 16 shows live cell images of 
stably expressing GFP constructs of Crb3a, Crb3b, Pals1 and 
transmembrane proteins, Crb3 isoforms localise at the plasma membrane of the cells, 
while Pals1 as a cytoplasmic protein is mainly found in the perinuclear area. 
CT is also found at the plasma membrane, although only the 
the C-terminal part of Nephrin is fused to the GFP
Crb3. Additionally to the mentioned GFP 
for the expression of the SNAP
Figure 16: Constructs of Crb3
localised in cultured podocytes
CT constructs in AB8 is shown by live cell imaging. (B
by immunoblot analysis. (B) Lysates were prepared from stable AB8 cell lines expressing GFP (control), GFP
Crb3a (middle panel) and GFP-Crb3b (righ
control. (C) Lysates were prepared from stable AB8 cell lines expressing GFP (contr
GFP-Pals1xSnap-Crb3a (3rd panel) and GFP
Snap shows expression of Pals1 and 
GFP-fpNephrin-CT. GFP antibody was used for GFP
The expression levels of some of the 
in the immunoblots in figure 16
loaded into each lane for each protein. The e
detected as calculated at approximately 55kDa 
Crb3a) in AB8 cells, by using a GFP (JL
at 35kDa (Fig.16, B).  
Furthermore, expression of GFP
shown in figure 16, section 
________________
Crb3, Pals1 and fpNephrin
cultured human podocyte (
fpNephrin
C-terminus is used, because 
-tagged transmembrane
expression cassettes, we established constructs 
- and 3xFLAG-tagged fusion proteins. 
, Pals1 and fpNephrin-CT are properly expressed and 
. (A) Proper expression of tagged Crb3a, Crb3b, Pals1 and 
-D) Expression levels in AB8 cell lines 
t panel). Antibody staining against α-actinin
ol), GFP
-Pals1xSnap-Crb3b (last panel). Antibody staining against GFP and 
Crb3 isoforms. (D) Lysates were prepared from AB8 cell lines expressing 
-fpNephrin-CT detection. Scale: 20µm.
utilised cell lines in this work are presented 
, B-D. For immunoblotting 10µl of proteinlysate was 
xpression of GFP-Crb3 isoforms was 
(with Crb3b being a few kDa bigger than 
-8) antibody. GFP alone (control) showed a signal 
-Pals1 and GFP-Pals1 with Snap
C. GFP-Pals1 is detected at 100kDa and Snap
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-CT 
AB8) cell lines 
-CT. Being 
fpNephrin-
 domain of 
 
fpNephrin-
are demonstrated 
-
-4 served as loading 
-Pals1 (2nd panel), 
 
-Crb3 isoforms is 
-Crb3a/b at 
 ________________________________
 
around 35kDa. Expression of GFP
calculated (Fig.16, D).  
 
Figure 17: PNGase assay. Lysates were prepared from stable AB8 cell
GFP-Crb3b (upper panel) and AB8 cell lines expressing 3x
were split into PNGase treated (+) and PNGase non
antibodies were used for detection. 
Next we tested, whether the Crb3 isoforms as type I transmembrane fusion 
proteins are correctly inserted into the plasma membrane due to posttranslational 
modifications, the GFP-Crb3 as well as 3xFLAG
approaches: one was treated with PNGase F for 30min (+), the other remained untreated 
(-), before being loaded on the SDS
were applied.  
PNGase F is an amidase and treatment of proteins 
GlcNAc (N-acetylglucosamines) and a
those residues leads to a slightly lower protein 
where the treated protein 
samples (Fig.17).  
Accordingly, not only are the generated expression cassettes expressed but also 
modified correctly in mammalian cell lines.
4.2.2 Overexpression of
Formation in Cultured Podocytes
Live cell imaging of AB8 cell lines stably expressing 
fpNephrin-CT exhibits cells forming junction
cells (Fig.18, A). Cells (GFP-
with other cells at their cell borders generating a large area of cell
GFP control cells do not show any signs of increased junction formations. 
Wheat germ agglutinin (WGA) is a lectin that binds glycoproteins on cell surfaces 
illustrating these for live cell imaging. 
therefore GFP cells do not exhibit 
WGA to visualise cell borders. 
________________
-fpNephrin-CT shows a protein size of 75kDa, as 
 
 lines expressing GFP
FLAG-Crb3a and 3xFLAG-Crb3b (lower panel). Lysates 
-treated (-) samples for direct comparison. GFP and M2 
-Crb3 protein samples were split 
-PAGE. For detection GFP and FLAG
conducts to 
sparagine from N-linked glycoproteins. Removal of 
size, as can be seen in the immunoblot
samples (+) show a smaller size than 
 
 Crb3 or fpNephrin-CT Induces J
 
GFP-Crb3 i
-like structures compared to AB8 GFP control 
Crb3a, GFP-Crb3b and GFP-fpNephrin-CT
-cell contacts, while 
Since GFP alone is not membrane bound 
clear cell borders, GFP control cells were stained with 
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-Crb3a and 
into two 
 (M2) antibodies 
cleaving between 
 C, 
the untreated (-) 
unction 
soforms and GFP-
) seem to overlap 
 
and 
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Figure 18: Overexpression of 
in cultured podocytes. (A) Immunofluorescence analysis of AB
Crb3a (2nd row), GFP-Crb3b (3rd row
cell lines but the control. GFP control cell line is stained with WGA (red) to highlight cell borders. Marked in 
white are areas exhibiting overlapping cell zones
AB8 cell lines shown for expans
quantification for junction-like formation
isoforms and fpNephrin-CT overexpressing cell lines compared to control c
quantification for junction-like formations 
Crb3 isoforms and fpNephrin-CT 
calculated: means ± SEM; *** p<0.001]. Scale: 20µm. 
To confirm the first visual impression, a quantitative analysis was conducted 
(Fig.18, B). For that purpose, cells were measured according to the length of the cell 
contacts with other cells as well as t
All cells except for control (GFP) show an extreme increase in the size of the 
overlapping area and especially in the length of cell contacts. Expression of GFP
and 3b shows a 5 times longer and GFP
compared to control. The same trend goes for junction expanse. The increase in the 
________________
Crb3 and fpNephrin-CT induces junction
8 cells overexpressing GFP (
), and GFP-fpNephrin-CT (last row) shows junction
, see magnified areas. (B) Quantitative analysis of mentioned 
e as well as length of junction-like formations. Graph on 
s in expanse indicating a significantly larger overlapping area for Crb3 
ell line. Graph on bottom presents 
in length highlighting a significantly longer cell
overexpressing cell lines compared to control cell line. [values Anova 
 
he size of the junction area (see 3.3.6.). 
-fpNephrin-CT up to four times longer cell contact 
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-like formations 
1st row), GFP-
-like formations for all 
top shows 
-cell border contact for 
 
-Crb3a 
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expanse of cell-cell contacts goes from 6 (GFP
compared to GFP control. Both changes, junctio
are highly significant (p<0.001).
Since the expression of Crumb3 isoforms as well as the 
protein Nephrin leads to a junction
look at the proteins localising in the junctional area. 
4.2.3 Overexpressed 
Junction Protein ZO
Immunofluorescence staining of fixed AB8 cells 
Crb3b, GFP-fpNephrin-CT and GFP
protein ZO-1 at the cell borders of all stained cell lines, but only a co
concentration of ZO-1 with 
adherens junction protein ß
co-localisation with Crb3a and Crb3b
further approve a development of a junctional formation in immortalised human 
podocytes, when Crb3 or fpNephrin
Figure 19: Overexpressed 
protein ZO-1 in cultured podocytes
GFP-Crb3a (second row), GFP-Crb3b (th
Merge of ZO-1 staining and GFP expression is presented in the 
at cell borders are shown in the 2nd (GFP), 3rd (
________________
-fpNephrin-CT) to 8 (GFP
n formation length as well as expanse, 
 
C-term of slit diaphragm 
-like structure, it seemed obvious, to take a closer 
 
Crb3 and fpNephrin-CT Co-localise with 
-1 in Cultured Podocytes 
stably expressing GFP
 as control shows a localisation of the tight junction 
Crb3 isoforms and fpNephrin-CT (Fig. 19
-catenin shows a localisation at cell borders as well as a 
 in AB8 cells (data not shown). These stainings 
-CT is overexpressed. 
Crb3 and fpNephrin-CT co-localise with tight junction 
. Fixed AB8 cells overexpressing GFP (control, 
ird row) and fpNephrin-CT (last row) were stained with ZO
first column. Magnified areas of co
ZO-1) and 4th (merge) column. Scale: 20µm.
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-Crb3a) times 
Tight 
-Crb3a, GFP-
-localisation and 
). Staining of the 
 
1st row), 
-1 antibody. 
-localisation 
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4.2.4 Co-expression of 
Crb3 from the Plasma Membrane
Given that both Crb3
cells, it was of interest to see, what effect it wou
were co-expressed in AB8 cells.
Figure 20: Co-expression 
partial co-localisation and expulsion of 
imaging shown of Snap-Crb3a (upper row) and Snap
in AB8 cells. Third column presents merge of GFP
Magnified areas of co-localisation are shown 
Quantitative analysis of AB8 cell lines expressing GFP
First graph presents analysis of AB8 cell line co
localisation of Nephrin (black column) and Snap
presents analysis of AB8 cell line co
Nephrin (black column) and Snap-Crb3b (white column) at the plasma membrane. [values t
means ± SEM; *** p<0.001]. Scale: 20µm. 
Stable expression of GFP
respectively, shows a typical 
approaches, while both Crb3
plasma membrane (Fig.20, A) as in cells expressing only 
both Crb3 isoforms seem to localise at least partly in vesicle
in figure 20, A (white circles). 
________________
Crb3 and fpNephrin-CT Induces 
 in Cultured Podocytes
 isoforms and fpNephrin-CT show the same effect in AB8 
ld have, if Crb3a/3b and 
  
of Crb3 and fpNephrin-CT in cultured podocytes
Crb3 from the plasma membrane.
-Crb3b (second row) co-expressed with GFP
-fpNephrin-CT with Snap-Crb3a or Crb3b, respectively. 
on the far right. Circles indicate co-localisation in vesicles. (B) 
-fpNephrin-CT with either Snap-
-expressing GFP-fpNephrin-CT with
-Crb3a (white column) at the plasma membrane. Second graph 
-expressing GFP-fpNephrin-CT with Snap-Crb3b showing localisation of 
 
-fpNephrin-CT with Snap-Crb3a and Snap
fpNephrin-CT expression at the plasma membrane for both 
 forms are mainly located in vesicles and a lot less at the 
Crb3 (see Fig.
s with fpNephrin
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Expulsion of 
 
fpNephrin-CT 
 
 shows 
 (A) Live cell 
-fpNephrin-CT 
Crb3a or Snap-Crb3b. 
 Snap-Crb3a showing 
-test calculated: 
-Crb3b, 
). Furthermore, 
-CT, as seen 
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To confirm the first visual impression, a quantitative analysis was conducted 
(Fig.20, B). For that purpose, around 50 cells of each cell line were taken into account. 
For analysing the distribution of co-expressed Crb3 and fpNephrin-CT in AB8 cells, every 
cell was evaluated according to whether the recombinant protein was localised at the 
plasma membrane or not. Analysis reveals that Nephrin is located at the plasma 
membrane in all accounted cells, while Crb3a as well as Crb3b remain in vesicles and are 
found at the plasma membrane in only about 20% of all accounted cells (Fig.20, B). Both 
analysis are highly significant (p<0.001) 
It seems that Nephrin is dominant in relation to Crb3 regarding their position, 
hence, expulsing Crb3 from the plasma membrane. This indicates a relation and 
dependence of slit diaphragm proteins to the Crumbs complex.  
4.2.5 Co-expression of Crb3a and Crb3b Induces Expulsion of Crb3a 
from the Plasma Membrane in Cultured Podocytes 
Since fpNephrin-CT seems to lead to an expulsion of Crb3a and Crb3b in AB8 cell 
lines, it was of interest to take a look at the properties of Crb3 isoforms when stably 
co-expressed in AB8 cells.  
Stable expression of both Crb3 isoforms in AB8 shows an unusual distribution. 
Both forms, when individually expressed in AB8 cells, localise at the plasma membrane 
(see Fig.18, 4.2.1). When co-expressed, Crb3a is found mainly in vesicles, while Crb3b 
remains localised at the plasma membrane (Fig.21, A).  
Confirmation of the observable effect was adduced by a quantitative analysis 
(Fig.21, B). To this end, about 100 cells were taken into account. Every cell was 
evaluated according to whether the recombinant protein was localised at the plasma 
membrane or not. Analysis shows a significant (p<0.001) reduction down to 30% of 
Crb3a presence at the plasma membrane, while Crb3b remains membrane bound in 
almost 100% of all accounted cells,  suggesting an expulsion of Crb3a by Crb3b.  
It seems in this case, Crb3b is dominant to Crb3a regarding their localisation, 
probably due to their different PDZ domain.  
Conclusively, Crb3b might play a more important role defining the plasma 
membrane in podocytes than Crb3a does.  
 ________________________________
 
Figure 21: Simultaneous ov
podocytes induces expulsion of Crb3a at the plasma membrane.
cell line co-expressing Snap-Crb3a (left image) and GFP
right. (B) Quantitative analysis of AB8 cell line co
their localisation of Crb3a and Crb3b, respectively, at the plasma membrane. 
± SEM; *** p<0.001]. Scale: 20µm.
 
4.2.6 Crb3 and fpNephrin
Endosomes in Cultured Podocytes
Since the live cell imaging of AB8 cells co
fpNephrin-CT (4.2.4.) point to a common maybe even 
with slit diaphragm proteins, it was 
regarding Crb3 and fpNephrin
It has been shown previously by
Rab11-positive vesicles prior to mitosis, but whether 
human podocytes via Rab11 vesicles, has not been addressed so far.  
________________
erexpression of both Crumbs isoforms in 
 (A) Live cell imaging of AB8 
-Crb3b (middle image) with merged image on the far 
-expressing both Crb3 isoforms. Cells were analysed due to 
[values t-
 
-CT are Transported via Early and Recycling 
 
-expressing Crb3
connected transportation of Cr
of interest, to further investigate vesicle trafficking 
-CT (Fig.22).  
 Schlüter et al.115 that Crb3a is trafficked in 
Crb3 is transported in immortalised 
 
 Results 
53 
 
cultured 
test calculated: means 
 isoforms with 
b3 
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Figure 22: Crb3 and fpNephrin
endosomes. (A) AB8 cells expressing GFP
against early endosomes (2nd column). Merge of EEA1 staining and GFP expression is presented in the third 
column, while magnified areas of co
Snap-Crb3a (1st row) and AB8 Snap
before fixation. Merged image is presented in the third column, while magnified areas of Rab11 positive vesicles 
transporting Snap-Crb3a/b are shown
and stained with EEA1 antibody against early endosomes (
endosomes (2nd row). Merge of vesicle staining and fpNephrin
while magnified areas of co-localisation are shown in the last images. Circles indicate co
Scale: 20µm. 
________________
-CT are mainly transported via early and recycling 
-Crb3a or GFP-Crb3b were fixed and stained with EEA1 antibody 
-localisation in EEA1 positive vesicles are shown on the far right. (
-Crb3b cells (2nd row) were transfected with GFP
 on the far right. (C) AB8 cells expressing GFP-fpNephrin
1st row) and with  Rab8 antibody against recycling 
-CT expression is presented in the third colu
-
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B) AB8 
-Rab11 (2nd column) 
-CT were fixed 
mn, 
localisation in vesicles. 
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Here, we used AB8 cells stably expressing GFP-Crb3a, GFP-Crb3b and 
GFP-fpNephrin-CT, respectively, for either staining with selected antibodies against early 
endosomes (EEA1), late endosomes (Rab7), lysosomes (LAMP2) and recycling 
endosomes (Rab8/Rab11) or transfection with tagged constructs for vesicle trafficking 
(Rab11/EEA1/Rab7/LAMP2). 
Immunofluorescence staining (Fig.22, A) as well as transfection (data not shown) 
with EEA1 shows Crb3a, Crb3b and fpNephrin-CT in EEA1-positive vesicles. While 
fpNephrin-CT is also to some small extent present in Rab8-positive vesicles (Fig.22, C), 
neither Crb3a nor Crb3b could be confirmed in Rab8-positive vesicles (data not shown). 
But transfection with a GFP-Rab11wt construct exhibits Crb3a and Crb3b in Rab11-
positive vesicles in AB8 cells (Fig.22, B).  
Antibody staining and transfection of Rab7 (late endosome) and LAMP2 
(lysosome) reveal only few vesicles co-localising with Crb3a, Crb3b or fpNephrin-CT (data 
not shown). 
Therefore, it can be assumed, that Crb3 isoforms as well as fpNephrin-CT are 
mainly transported via early and recycling endosomes in immortalised human podocytes, 
suggesting rather a recycling of already established mentioned proteins at the plasma 
membrane than degradation and new assembly.  
4.2.7 Cyst Formation Assay of Crb3 Overexpressing MDCK Cells Leads 
to Increased Cyst Growth  
Previous reports with exogenous Crb3a in zebrafish123 and MDCK cell lines115 
revealed an induction of apical membrane expansion, an aspect that in regard to 
podocyte´s huge apical membrane is of revelance. Given that immortalised podocytes do 
not possess their apicobasal polarity in cell culture and since Crb3b expression seems to 
be more prominent then Crb3a in podocytes, it was worth to inquire the effect of 
exogenous Crb3b in a MDCK cyst formation assay.  
MDCK cells expressing GFP-Crb3a or GFP-Crb3b were grown in collagen for 5 
days, before fixation and staining. Cyst were stained either with ß-catenin or phalloidin 
for illustrating the junctional area or apical membrane. Exogenous expression of Crb3a as 
well as Crb3b shows cysts with a single lumen, as expected115 (Fig.23). Crb3b is 
predominantly localised at the apical membrane, with no localisation at the junctional 
areas (Fig.23, A). Even after only 5 days of growth, both cyst cell lines show obviously 
bigger cysts compared to GFP control cysts. Quantitative analysis of 50 cysts for each cell 
line in 3 independent approaches proves an increase in size up to 40% for GFP-Crb3a 
and 20% for GFP-Crb3b (Fig.23, C). Additionally, analysis of changes in lumen size 
shows an increase of the size of the lumen for GFP-Crb3a (80%) and GFP-Crb3b (40%) 
(Fig.23, C). Evaluation proved to be highly significant (p<0.001). 
 ________________________________
 
Conclusively, the increase in cyst size se
volume, but rather due to a higher cell number.
Figure 23: Cyst formation assay of GFP
leads to increased cyst growth.
Geltrex matrix for 5 days for a cyst formation assay, then fixed and stained for microscopy. (A) MDCK GFP
Crb3b cysts were stained with ß-catenin tight/adherens junction areas. Merge of GFP expression and staining 
are shown in the third column. (B) MDCK cysts with GFP
DAPI to highlight apical structures and nuclei. Merge of GFP expression and staining are shown in the third 
column. (C) Quantitative analysis of cyst size 
and GFP-Crb3b. [values t-test calculated: means 
Scale: 20µm. 
________________
ems not to be in regards to
 
-Crb3a and GFP-Crb3b expressing MDCK cells 
 (A,B) MDCK cells expressing GFP-Crb3a or GFP-
-Crb3a or GFP-Crb3b were stained with phalloidin and 
and lumen size after 5 days of growth for GFP control, GFP
± SEM; *** p<0.001, n=3 independent experiments]. 
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4.3 Analysis of Crb3 Interactions with Pals1 
Another crucial member of the Crumbs complex is Pals1. This study and previous 
work already showed that Pals1 is highly expressed in renal epithelial cells, especially in 
podocytes (4.1.).118 It was shown, that a knockdown of Pals1 in renal epithelial cells 
(MDCK cells) leads to a delay of tight junctions formation, impaired development of 
luminal cysts and polarity defects in MDCK cyst formation assays.72 Walsh and colleagues 
provided evidence for the importance of Pals1 in development of neuronal progenitor 
cells further determining the role of Pals1 in cell polarity generation and perpetuation.105 
Although, it has been shown through pull-down assays that Pals1 directly interacts with 
Crb3a50, not much is known about the molecular and physiological features of Pals1. 
Since some of the Pals1 domains are still not analysed regarding interaction partners and 
function, we assumed a possible interaction between Pals1 and Crb3b, particularly in 
podocytes. Therefore, we conducted live cell imaging of AB8 cells expressing exogenous 
Pals1 with Crb3a and Crb3b as well as yeast two-hybrid interaction studies to investigate 
a possible dependence between Pals1 and Crb3b. 
4.3.1 Co-expression of Pals1 and Crb3 Leads to Recruitment of Pals1 
to the Plasma Membrane in Cultured Podocytes 
Live cell analysis of AB8 cells expressing retroviral-mediated Pals1 show a mostly 
perinuclear distribution of GFP-Pals1. To some extent, these cells exhibit GFP-Pals1 near 
the plasma membrane (Fig.24, A first row). However, co-expression of exogenous Pals1 
with Crb3a shows a relocation of Pals1 to vesicles and the plasma membrane, whereas 
co-expression of exogenous Pals1 with Crb3b shows only a minimal relocation of Pals1 to 
the plasma membrane, but not a increased localisation in vesicle compartments (Fig.24, 
A, second to third row). For analysing the localisation of Pals1 in AB8 cells when co-
expressed with either Crb3a or Crb3b, every cell was evaluated according to whether or 
not Pals1 was localised at the plasma membrane, the cytoplasma or in vesicles (see 
3.3.6.). 
Quantitative analysis of approximately 100 cells of each cell line illustrates the 
distribution of Pals1 for each cell line (Fig.24, B). AB8 cells co-expressing Pals1 with 
Crb3a illustrate a 20% increased localisation at the plasma membrane and a 50% more 
frequent localisation in vesicles, while the perinuclear position decreased up to 50% 
compared to Pals1 alone.  
 ________________________________
 
Figure 24: Co-expression of Pal
plasma membrane. (A) Live cell imaging of AB8 cell lines expressing GFP
expressing GFP-Pals1 with Snap-Crb3a (
of GFP-Pals1 with Snap-Crb3a or Snap
on the far right. (B) Quantitative analysis of Pals1 distribution in GFP
GFP-Pals1 with Snap-Crb3b cell lines. Cells were evaluated according to whether or not GFP
at the plasma membrane, the cytoplasma (perinuclear) or in vesicles (<50). [values Anova calculated: means 
± SEM; *** p<0.001]. Scale: 20µm. 
Though, for AB8 cells co
shows a minimal increase of 10% at the plasma membrane, but no increase in vesicle 
localisation or decrease in perinuclear localisation.
________________
s1 and Crb3 leads to recruitment of Pals1 to the 
-Pals1 (
2nd row) and with Snap-Crb3b (3rd row). Third column prese
-Crb3b, respectively. Areas of Pals1 and Crb3 localisation are magnified 
-Pals1, GFP-Pals1 with Snap
 
-expressing Pals1 with Crb3b, the distribution of Pals1 
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Pals1 to the 
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plasma membrane, while Crb3b does
proved to be highly significant (p<0.001). 
Conclusively, it can be said, that Pals1 is recruited by Crb3a to vesicles and the 
plasma membrane, while Crb3b does not seem to have the same effect. Nevertheless, 
Crb3b does increase the presence of Pals1 at the plasma membrane
4.3.2 Pals1 Interacts 
Since immunofluorescence analysis of 
Crb3 isoforms show a dependence between one another, a yeast 
study has been undertaken between Pals1 and Crb3a/3b. The interaction study reveals 
only an direct interaction between Pals1 and Crb3a
plates in figure 25, A. Direct 
since there is no yeast growth on 
yeast growth strength for comparison
Figure 25: Direct interaction only between Pals1 and Crb3a but 
hybrid assay shows normal growth of yeast 
3rd column), while growth on –L/
column, upper panels) but not for Pals1 with Crb3b (2nd and 4th 
normal growth on –L/-W control plates (left 
growth for negative control (Pals1 vs. vehicle).
 
4.4 Analysis of Crum
Since two Crb3 mouse lines 
focused on Pals1 as another essential member of the Crumbs complex
binding partner, to analyse the Crumbs complex
mouse line that has been provided by Dr. Chris Walsh (Harvard Medical School, Boston, 
USA) to investigate the role of the Crumbs complex in renal function.
 
________________
 not have the same effect on Pals1. Evaluation 
 
. 
Directly with Crb3a but not Crb3b 
AB8 cells expressing exogenous Pals1 with 
two-
, proven by yeast growth on 
interaction between Pals1 and C-term Crb3b is not apparent, 
–L/-W/-H plates. Positive and negative control 
 (Fig.25, B). 
not Crb
for Pals1 with Crb3a and Crb3b on –L/-W 
-W/-H interaction plates only occurs for Pals1 with Crb3a (2nd and 4th 
column, lower panels). (B) Controls show 
column) and growth for positive control (Amot vs. PATJ) and no 
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4.4.1 Podocyte Specific (Pod
Observable Phenotype
Strong Pals1 expression in murine and human glomerular podocytes (see 4.1.1. 
and 4.1.2.) and in immortalized human podocytes
podocyte´s function.  
 To see what effect a loss of Pals1 expression in podocytes would have on 
podocyte structure and survival, 
crossing conditional knockout Pals1 mice with Pod
of both alleles (Pals1fl/fl PodCre+
Figure 26: Generation of homozygotic Pals1 floxed mice and deletion of Pals1 
selectively in podocytes. (A) Generation of renal glomerular podocyte
crossing of homozygotic Pals1fl/fl mice 
(red box). The Pals1wt/fl PodCre+ mice were used for the se
PodCre+ mice (yellow box). (B,C) Genotyping of generated Pals1 floxed mice. (B) Homozygotic and 
heterozygotic floxed Pals1 verified by PCR using DNA from tail biopsies. Floxed Pals1 allele (238bp) being 50bp 
bigger than wildtype allele (189bp). (C) Cre recombinase allele (450bp) verified by PCR using DNA from tail 
biopsies.  
________________
Cre) Knockout of Pals1 Shows no 
 
118 suggested an important role in 
deletion of Pals1 in mouse embryo podocytes
ocinCre mice. To achieve a full 
), two subsequent crossings were undertaken (
-specific Pals1 knockout mice. Firs
with PodCre+ mice led to 50% of heterozygotic Pals1wt/fl
cond crossing to obtain homzygotic Pals1
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Heterozygotic and homozygotic floxed Pals1 alleles as well as Cre recombinase 
allele were verified by PCR using DNA from tail biopsies (Fi
Pals1fl/fl PodCre+ mice urine was compared to Pals1
albumin standard. Urine analysis 
(data not shown) exhibits no proteinuria. Hence, Pals1
phenotype, meaning there was no significant change in body size, body weight, survival 
or health condition (data not shown) within 12 months after birth. 
To prove the activity of podocin regulated Cre recombinase activity, mouse kidn
sections of 5 week old mice were prepared.
antibody of the PodCre- mice show a distinct staining of the podocytes in the glomeruli and 
the apical membrane in tubuli. However, Pals1
visible staining of the glomeruli, but of the apical membrane of the tubuli surrounding the 
glomerulus (Fig.27, A). 
Figure 27: Podocyte specific knock
kidney sections of Pals1fl/fl (left image) and Pals1
antibody and DAPI, showing no Pals1 detection in glomeruli of Cre positive mice.
Pals1fl/fl PodCre+ mice exhibit no proteinuria at age 
albumin standard for comparison and Pals1
each lane of the SDS-PAGE.  
 
4.4.2 Kidney Development Specific (Six2
Pals1 Shows Strong Phenotype
Since Podocin expression
wondered, whether Pals1 expression
development.  
Therefore, floxed Pals1
a mouse line that lacks Pals1
ureteic bud (first stages of metanep
________________
g.26, B and C). 
fl/fl PodCre- mice urine and 1µg 
of 5 week old mice (Fig.27, B) and of 8 month old mice 
fl/fl PodCre+ mice show no obvious 
 
 The kidney section staining with the Pals1 
fl/fl PodCre+ kidney sections 
out of Pals1 shows no obvious phenotype.
fl/fl PodCre+ (right image) mice were stained with Pals1 
 (B) SDS
of 5 weeks. 1µg BSA (lane next to marker) was used as 
fl/fl mice as negative control. 6µl microliter urine was loaded into 
Cre) Heterozygotic Knock
 
 starts not until late capillary loop stage
 might have a more essential role in early 
 mice were crossed with Six2Cre mice meaning to generate
 from the induction of the metanephric mesenchyme by the 
hric development).111 
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Pals1fl/fl mice were breed with 
Pals1wt/fl Six2Cre+ mouse line (
recombinase allele were verified by PCR using DNA from tail biopsies (
Figure 28: Kidney development specific heterozygotic knock
heterozygotic floxed Pals1 Six2Cre+ mice. Crossing of homozygot
50% of heterozygotic Pals1wt/fl Six2
DNA from tail biopsies. Floxed Pals1 allele (238b
recombinase allele (450bp) verified by PCR using DNA from tail biopsies. 
4.4.2.1 Six2 Specific
Body Size and Weight 
Heterozygotic knockdown of Pals1 shows a stron
during the first weeks after birth. 
phenotype was seen by two 
size and weight are visible after 3
negative littermates. Body size is significantly lower during the first 
most prominent from the age of 3 weeks (
lower starting from birth but shows a remarka
between Pals1wt/fl Six2Cre+ and Cre negative littermates (Fig.
Evaluation of body size and weight of Pals1
negative littermates as control 
________________
Six2Cre positive mice generating a heterozygotic 
Fig. 28, A). Heterozygotic floxed Pals1 alleles as well as Cre 
Fig.28
out of Pals1.
ic Pals1fl/fl mice with Six2
Cre+ mice (red box). (B) Heterozygotic floxed Pals1 verified by PCR using 
p) being 50bp bigger than wildtype allele (189bp). (C) Cre 
 
 Knockout of Pals1 Leads to Impairments in 
g phenotype that is observable 
Pups were indistinguishable at birth. No 
weeks of age. However, Pals1wt/fl SixCre+ mice impairments in 
-4 weeks of age (Fig.29, A) compared to Pals1
Fig.29, B). Body weight is also
ble discrepancy at the age of 
29, C).  
wt/fl SixCre+ mice 
are highly significant (n=9; p<0.001). 
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 (A) Generation of 
Cre+ mice led to 
apparent 
wt/fl Cre 
two weeks but is 
 apparently 
four weeks 
and Pals1wt/fl Cre 
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Figure 29: Heterozygotic kidney development specific knockout of Pals1 leads to 
impairments in body size and weight.
in mice led to  impairments in body size 
weight were observable by 3 weeks 
significantly smaller by four weeks of age, compared with Cre negative liitermate
Body weight of Pals1wt/fl Six2Cre+ mice was significantly smaller by 
negative littermates [*** p<0.001; n=9]. 
4.4.2.2 Six2 Specific
Median Survival of 40 days
Since Pals1wt/fl SixCre+
whether the observable phenotype is due to podocyte dysfunction. On these grounds, 
urine analysis of Pals1wt/fl 
conducted. Two week old control mice do not reveal any signs of proteinuria with 1µg 
________________
 (A,B,C) Deletion of one Pals1 allele during kidney development 
as well as body weight (age: four wks). (A) Reduced body size and 
of age. (B) Pals1wt/fl Six2Cre+ mice exhibited growth retardation and were 
s [*** p<0.001; n=9]. (C) 
four weeks of age, compared to Cre 
 
 Knockout of Pals1 Leads to Proteinuria and 
 
 mice show an obvious phenotype, it was important to see 
SixCre+ mice compared to Cre negative littermates were 
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and 5µg BSA for standard comparison, while Pals1
proteinuria (Fig. 30, A; red asterisks
Figure 30: Heterozygotic kidney development specific knockout of Pals1 leads to 
proteinuria and a median survival of 40 days.
urine (No. 2 and 4) exhibits proteinuria (red 
marker) were used as albumin standard for comparison and Pals1
control. (B) SDS-PAGE assay of same mice (No. 2 and 4) three days later shows significantly increased 
proteinuria (red stars). 6µl microliter of u
Kaplan-Meier estimation of Pals1wt/fl Six2Cre+ mice and litter
mice is 40 days [*** p<0.001; n=9
The severe and rapid progress of proteinuri
same mice three days later. At the age of 17 days 
demonstrate an enormous rise in albumin in their urine (Fig.
considerable progress of proteinuria within a few da
survival prospects of Pals1wt/fl
________________
wt/fl SixCre+ mice prove to have a severe 
).  
 (A) SDS-PAGE assay of Pals1
asterisks) by day 14 of age. 1µg and 5µg BSA (lanes next 
wt/fl littermates (No. 11 to 13) as negative 
rine from each mouse was loaded into each lane of the SDS
mates. Median survival of Pals1
].  
a is evidenced by urine analysis of the 
the same proteinuric mice 
30, B, red 
ys is surely a reason for the low 
 SixCre+ mice monitored during the first 5-
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Kaplan-Meier estimation reveals a median survival of 40 days
compared to Cre negative littermates (
20. Evaluation of survival of Pals1
proved to be highly significant (
4.4.2.3 Six2 Specific
Polycystic Kidneys 
Additionally to proteinuria and poor survival outcome, unsurprisingly heterozygotic 
floxed Pals1 Six2Cre+ mice have severely damaged kidneys. On first sight, kidneys of 
Pals1 Six2Cre+ mice exhibit kidneys with huge amounts of cysts. There is very little
tissue recognisable, but a lot of fluid filled 
Figure 31: Heterozygotic ki
development of polycystic kidneys. 
(right image). Kidneys were explanted from Pals1
littermates (right kidney). Control 
pathological changes similar to polycystic kidneys (age: 
reveal significant differences. (Bi) Control mice show normal kidney morphology. 
magnified. (Bii) Magnified areas of cortex (upper ima
glomeruli and tubuli. Black boxes indicate areas 60x magnified (bottom images). (Ci) 
littermates display a high amount of cystic structures especially in the cortex. Black boxes in
magnified. (Cii) Magnified areas of cortex (upper image) and cortex/medulla border (lower image) show altered 
glomeruli and tubuli as well as a high number of cystic cavities. Black boxes indicate areas 60x magnified 
(bottom images). 
________________
 for Pals1
Fig.30, C), with mice beginning to die from day 
wt/fl SixCre+ mice and Pals1wt/fl Cre negative littermates
p<0.001). 
 Knockout of Pals1 Leads to Development of 
cavities (Fig.31, A). 
dney development specific knockout of Pals1 leads to the 
(A) Images taken of whole kidneys (left image) and frontal cuts 
wt/fl Six2Cre- mice (left kidney) and Pals1
mice show normal kidneys, Pals1wt/fl Six2Cre+ littermates exhibit 
four weeks). (B-C) PAS staining of kidney sections 
Black boxes indicate areas 20x 
ge) and cortex/medulla border (lower image) show normal 
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PAS (periodic acid-Schiff) stained kidney sections reveal normal kidney 
morphology for control littermates (four weeks of age), showing distinguishable cortex 
and medulla, normal glomeruli and tubuli development, and only few lesions due to 
sectioning (Fig.31, B). In contrast, kidney sections of Pals1 Six2Cre+ mice reveal a 
completely different kidney morphology. Some huge cavities and a lot of smaller ones are 
found in the renal cortex and renal medulla, as well as a dilation of the renal pelvis 
(Fig.31, C). Magnifications show damaged glomeruli and tubuli. Tubuli are dilated and 
fuse with neighbouring tubuli forming cystic cavities. Glomeruli are barely present or 
developed in the renal cortex, while juxtamedullary glomeruli show severe damages with 
withering capillary loops, dilating Bowman´s capsules and apoptotic glomerular cells 
(Fig.31, Cii). 
4.4.2.4 Quantitative Analysis of Alterations in Glomeruli and 
Development of Cysts 
Quantitative analysis and evaluation of glomeruli damage was done by measuring 
glomeruli size and counting the total number of glomeruli per kidney section. To estimate 
the progress in glomeruli damage, the expanse of intraglomerular space of the nephrons 
was measured (Fig.32).  
The obvious damage to glomeruli can be seen in figure 32, A. The total number of 
glomeruli present in the kidney sections is significantly lower Pals1wt/fl Six2Cre+ mice 
compared to control littermates (Fig.32, B). The size of existing glomeruli is increased by 
20% compared to control (Fig.32, C), while the distance between visceral to parietal cells 
is considerably high in Pals1wt/fl Six2Cre+ mice, up to 5 times longer than in control 
littermates (Fig.32, D).  
For all analysis three Pals1wt/fl Six2Cre+ mice and three Cre negative control 
littermates were included.  
Quantitative analysis and evaluation of cystic formations was done by counting 
the number of cysts and measuring the expanse of cystic cavities per kidney section.  
The cystic cavities seen in PAS stained kidney sections in figure 33, A of Pals1wt/fl 
Six2Cre+ mice and control littermates, are large in number and expanse. The total number 
of cystic cavities is significantly high in Pals1wt/fl Six2Cre+ mice, in fact 10 times higher 
than in control littermates. Actually, Cre negative control mice should not show any 
cysts, but sectioning can lead to lesions in the tissue. To avoid any mistakes in 
quantifying the cystic cavities, every cyst-like cavity larger than 1000µm2 was counted as 
a cyst (Fig.33, B).  
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Figure 32: Heterozygotic kidney dev
severe alterations in glomerular development and preservation.
sections reveal significant pathological a
image) show normal glomerular and tubular morphology. 
and abnormal glomerular structures. (B,C,D) Quantitative analysis of glome
Six2Cre+ and control littermates. (B) Number of
Size of glomeruli is slightly increased for Pals1
between visceral to parietal cell layers is 
littermates. [values t-test calculated: means 
Not only did we count the total number of cysts but we also measured the 
expanse of those cysts. It turns out, that there are some cysts larger than 5
to cyst expanses of 1.4mm2
5000µm2 (Fig.33, C). 
For all analysis three Pals1
littermates were included.  
 
________________
elopment specific knockout of Pals1 exhibits 
 (A) PAS staining of kidney 
lterations (magnification: x60; age: four wks
Pals1wt/fl Six2Cre+ littermates display cystic cavities 
rular differences between Pals1
 glomeruli is severely decreased in Pals1
wt/fl Six2Cre+ compared to control littermates. (D) Distance 
drastically increased for Pals1wt/fl Six2Cre+ compar
± SEM; *** p<0.001; n=3]. 
 and a large number of cystic spaces ranging from 1000 to 
wt/fl Six2Cre+ mice and three Cre negative control 
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Figure 33: Heterozygotic kidney development specific knock
development of cysts. (A) PAS staining of kidney sections reveal a high num
Pals1wt/fl Six2Cre+ mice compared to Cre
renal cysts in Pals1wt/fl Six2Cre+ mice compared to control littermates. (B) Number of cystic cavi
extremely high in Pals1wt/fl Six2Cre+ mice [values t
Not only the number of cystic cavities is particularly high, but also the expanse of individual cysts. 
larger than 1000µm2 were valued as cysts in sections of Pals1
[values t-test calculated: means ± SEM; ***
4.4.2.5 Semi-Thin Cross Sections and Electron Microscopy Show 
Pathological Alterations in Tubuli and Glomeruli
Semi-thin cross section
were done to further analyse the pathological changes specifically in 
34 shows a close-up view of a glomerulus with three distinct alteration
massive enlargement of the mesangial capillary tuft, including collapsing capillaries; (2) 
observable are areas of capillaries with podocytes comp
and the glomerular basement membrane being the outer border to the urinary space; (3) 
there are podocytes detaching from the GBM and attaching to the parietal layer of the 
Bowman´s capsule, developing cystic cavities and, 
________________
out of Pals1 exhibits 
ber of cystic cavities in 
 negative littermates (four weeks). (B,C) Qu
-test calculated: means ± SEM; *** p<0.0003; n=3]. (C) 
wt/fl Six2Cre+ as well as control littermates 
 p<0.001; n=3]. 
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Figure 34: Semi-thin cross section of a Pals1wt/fl Six2Cre+ mouse. 
Pals1wt/fl Six2Cre+ mouse stained with methylene blue shows (1) a massive enlargement of mesangio
capillary regions with collapsing capillaries
podocytes with cystic cavities and incorporation into the parietal cell layer, developing crescent shaped scars. 
(in cooperation with W.Kriz, Univers
Figure 35: Electron microscopy analysis of glomerular filtration barrier in Pals1wt/fl 
Six2Cre+ mice. Microscopy analysis of Pals1wt/fl control mice and Pals1wt/fl Six2Cre+ mice shows no 
alterations of the glomerular basement membrane (black asterisk) or the foot process of the podocytes (red 
asterisk). Even the slit diaphragm between foot processes looks normal and undisrupted. 
________________
, (2) loss of podocytes with denuded capillaries, and (3) detaching 
ity of Heidelberg) 
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Since the Pals1wt/fl Six2Cre+  mice develop a severe proteinuria and the damage to 
the glomeruli is apparent in semi-thin cross sections (Fig.34), including detachment of 
the podocytes, impairments to the slit diaphragm were expected. However, electron 
microscopy analysis of the filtration barrier in Pals1wt/fl control and Pals1wt/fl Six2Cre+ mice 
demonstrated – at least partially in some of the analysed glomeruli - an intact slit 
diaphragm in normal looking glomeruli, suggesting a correct establishment of the slit 
diaphragm during development (Fig. 35). The GBM (black asterisk) and the attached foot 
processes of the podocyte (red asterisk) look normal, including an intact slit diaphragm 
between foot processes. 
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5 Discussion 
Podocytes are highly polarised epithelial cells contributing significantly to the 
filtration barrier by generating the slit diaphragm. Podocyte damage, a key feature of all 
glomerular diseases, is accompanied by foot process effacement and functional 
deficiencies in the slit diaphragm, resulting in massive proteinuria, clinically progressing 
to a nephrotic syndrome and end stage renal disease.94  
Different studies assume an essential role for the apical Par complex in podocytes 
functionality.124,125 Moreover, the role of the Crumbs complex for cell polarity and 
integrity has been shown in diverse epithelial tissues, suggesting an equally important 
role for the Crumbs complex in the cell polarity of renal cells, especially in podocytes and 
their slit diaphragm formation.32,49,54,65,105 
Therefore, this work focused on the functional analysis of Crb3 and Pals1 in 
podocytes.  
5.1 Expression of the Crumbs Complex in Renal Epithelia 
Crb1 and Crb2 are mainly expressed in retina and brain, with Crb1 mutations 
being involved in several severe ophthalmic diseases, while Crb3 expression is primarily 
high in skeletal muscle and virtually all epithelial tissues, including the kidney.50–53 The 
scattered expression pattern of different Crumbs proteins suggests a specific function for 
each Crumbs protein connected to the particular tissue and cell type. Although there is a 
diverse expression pattern, Crumbs proteins and their interaction partners (Pals1, Par6) 
are always involved in the regulation of cellular polarity and determination of the apical 
membrane.65,67 Surprisingly, although the Crb3a PDZ domain ERLI seems to be crucial 
for tight junction formation, it is not involved in the localisation and definition of the 
apical membrane. This is, at least partially, dependent on the FERM binding domain, a 
domain shared by both Crb3 isoforms, suggesting a role for Crb3b in the definition of the 
apical membrane.66,83 
To determine whether the Crumbs complex plays a role in the kidney, it was 
necessary, to survey the expression of the Crumbs complex members, Crb3a/b and 
Pals1, especially in glomeruli and podocytes. This was established by staining of murine 
and human kidney sections with antibodies against Crb3a, Crb3a/b and Pals1. To 
highlight the podocytes in these sections, they were co-stained with antibodies against 
podocyte-specific marker proteins Nephrin and wilms tumor 1 (WT-1; see 4.1.1).  
We detected high expressions of Crb3 and Pals1 in murine and human kidney 
sections, specifically in the visceral cell layer (podocytes), proven by co-localisation with 
Nephrin and WT-1, and the apical domain of the tubuli. This indicates a basic role for 
Crb3 and Pals1 in podocytes. 
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Since there was no Crb3b specific antibody available, another approach to verify 
the Crb3b expression was undertaken. For that purpose, analysis of mRNA extracted 
from immortalised murine podocytes (K8), isolated murine glomeruli and primary 
isolated murine podocytes were performed. Interestingly, a higher expression for Crb3b 
than Crb3a and no expression for Crb1 was seen (4.1.2). This underlines the high levels 
of Crb3b and Crb3a in podocytes in vivo, further depicting an important role for the 
Crumbs complex in visceral epithelia.  
The higher expression levels of Crb3b compared to Crb3a suggest a more 
significant role for Crb3b in podocytes. To date, there is only one study on Crb3b 
revealing merely a role in ciliogenesis and cell division.62 Since the podocyte is 
post-mitotic and does not present a primary cilium, our data indicate a different role in 
podocytes than other epithelial cells. The specification and regulation of the apical 
membrane and its size is assumingly more dependent on Crb3b, while Crb3a might be a 
more essential regulator for junctional establishment and maintenance due to its PDZ 
domain ERLI. To examine this possibility, overexpression of both Crb3 isoforms in 
different cell lines cells had to be performed (see below). 
5.2 Analysis of Ectopic Crumbs Complex Members and 
fpNephrin-CT in Renal Epithelia 
To further elucidate the role of the Crumbs complex in renal epithelial cells, 
tagged constructs of Crb3a, Crb3b and Pals1, were generated and used for analysis in 
immortalised human podocytes (AB8) and Madine Darby canine kidney (MDCK) cells. The 
AB8 cell line was utilised, since it is known to be the best available podocyte cell line to 
work with in vitro. However, this cell line does not present apicobasal polarity in cell 
culture. Therefore, MDCK cells were utilised for approaches especially regarding 
apicobasal polarity. 
Recently a study of rats with treated puromycin-aminonucleoside, which induces a 
transient damage of the podocyte and proteinuria, revealed a decrease not only in 
Nephrin but also in Crb3, indicating an indirect connection between Crumbs complex and 
slit diaphragm proteins.99 To investigate the possible connection between the Crumbs 
complex and slit diaphragm proteins, a tagged fusion protein with the C-terminus of 
Nephrin was also generated.  
The correct expression and localisation was verified by immunofluorescence and 
immunoblot analysis showing proper expression for all tagged proteins with low levels of 
degraded proteins. Pals1 localisation is diffuse and predominantly in the cytoplasm, while 
the fusion protein Nephrin with its transmembrane domain of Crb3 as well as both 
transmembrane proteins Crb3a and Crb3b are mostly found at the plasma membrane 
(4.2.1.).  
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PNGase assays detected the correct N-glycosylation of the fusion proteins, 
confirming accurate posttranslational modifications and insertion into the cellular 
membranes.  
To prove that the localisation of our fusion protein Nephrin (fpNephrin-CT) is not 
dependent on the Crb3 domains attached to the Nephrin C-terminus (see 3.2.1.1.), a 
second chimeric Nephrin construct (CD16/7/nephrinCD) was used.126 Both constructs 
have the Nephrin C-terminus, but different transmembrane and extracellular domains. 
Immunofluorescence analysis of AB8 cells expressing both chimeric constructs should 
show a co-localisation if the Nephrin C-terminus depicts the localisation defining part of 
the protein. For visualising CD16/7/nephrinCD an antibody against CD16 was used. AB8 
cells co-expressing both fusion proteins show co-localisations in vesicles as well as the 
plasma membrane (data not shown). Supplementary, unpublished data by Margolis and 
our laboratory show a significance for the FERM binding domain in the localisation of Crb3 
at the plasma membrane while the absence of the cytosolic region of Crb3 leads to a 
failure in membrane insertion. Taken together, this denotes that the Nephrin C-terminus 
of fpNephrin-CT is the position defining region, and thus suitable for further studies.  
5.2.1 Crb3 and fpNephrin-CT in Cultured Podocytes 
Microscopy analysis of AB8 cells overexpressing GFP-Crb3a, GFP-Crb3b and 
fpNephrin-CT demonstrate an enlarged cell area that overlaps with adjacent cells, 
creating a junctional structure, compared to GFP control cell lines (see 4.2.2.). However, 
no change regarding membrane polarisation can be seen in z-stack microscopy analysis 
(data not shown). Measurements of the junction´s length and expanse revealed a 
significant increase.  
These data already indicate a junction-like structure, and staining with adherens 
junction protein ß-catenin reveals no increased localisation at the cell borders or 
co-localisation with either overexpressed protein (data not shown). However, staining 
with tight junction protein ZO-1 shows co-localisation with Crb3a, Crb3b and 
fpNephrin-CT at the junction-like formations (4.2.3.). Consequently, overexpression of 
Crb3 or Nephrin leads to an increase in cell-cell contacts in non-polarised podocytes 
under cell culture conditions indicating a possible role for either protein in the definiton of 
cell-cell contacts of podocytes in vivo.  
In fact, the expression level of Crumbs complex proteins in non-polarised cultured 
human podocytes is not high enough to be detectable with the currently available 
antibodies. Most in vitro studies regarding Crb3 and Pals1 were performed in highly 
polarised cells (e.g. MDCK) to observe the changes in the developing or already 
established cell polarisation due to mutations in Crb3 or Pals1. A moderate 
overexpression of Crb3a in polarised cells like MDCK leads to an expansion of the tight 
junction as well as apical membrane.32,66,105,115 
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 But one study showed that overexpression of Crb3a in non-polarised mammary 
MCF10A cells induces tight junction formation and recruitment of proteins, including 
ZO-1, from a diffuse and fragmented localisation in the cytoplasm to the apical cell-cell 
junctions.83 Accordingly, an overexpression of Crb3 isoforms in AB8 cells might induce a 
change in the membrane structure and junction formation. In fact, immunofluorescence 
analysis demonstrates a recruitment of ZO-1 from the cytoplasm to the junction-like 
formations in Crb3 overexpressing cells (4.2.3.). Strikingly, both Crb3 isoforms cause the 
same effect, suggesting either a regulation through the shared FERM binding domain or 
regulation through an interaction partner that is able to bind both PDZ domains, ERLI and 
CLPI. Yeast-two-hybrid screens for this study failed to reveal possibly significant 
interaction partners for the FERM or PDZ domain (data not shown).  
Although not much is known about the FERM binding domain and its interaction 
partners, some studies indicate a role in membrane size control and membrane stability 
through interactions with Yurt in Drosophila (YMO1 in mammals) and ß-Heavy-spectrin, 
respectively.60,127 Additionally, phosphorylation of two threonines in the FERM motif of 
Crumbs are crucial for membrane stability in Drosophila.128 Those threonine residues are 
highly conserved throughout the three Crumbs genes, indicating a similar role in 
mammals as in Drosophila. This explains the similar effect of both Crb3 isoforms, placing 
as much emphasis on Crb3b as on Crb3a for apical membrane size and stability.  
Tight and adherens junctions proteins are of major importance for cell polarity, 
thus Nephrin as a main member of the slit diaphragm, a modified version of the tight and 
adherens junction in podocytes, might be as important to the podocyte´s polarity.99,100 It 
is known, that Nephrin interacts either directly with the actin cytoskeleton (α-actinin-4) 
or through scaffold and adaptor proteins (IQGAP1, CD2AP, Nck).126,129–131 Nephrins 
influence on the cell´s cytoskeleton might be an explanation for the overlapping of 
adjacent cells, which might be due to an enlargement of the plasma membrane. 
Surprisingly, co-expression of fpNephrin-CT with either of the Crb3 isoforms 
shows a reduced presence of Crb3 at the plasma membrane, and a partial co-localisation 
in vesicular structures. Furthermore, Crb3a and Crb3b seem to be concentrated in 
vesicular compartments. Quantitative analysis reveals a significant decrease in cells 
presenting Crb3 at the plasma membrane compared to fpNephrin-CT (4.2.4.).  
Simultaneous expression of both Crb3 isoforms shows an equally unusual 
distribution. Both forms, when individually expressed in AB8 cells, localise at the plasma 
membrane (4.2.5). When co-expressed, Crb3a is found mainly in vesicular structures, 
while Crb3b remains localised at the plasma membrane. Quantitative analysis shows a 
significant decrease in Crb3a localisation at the plasma membrane in the presence of 
Crb3b. 
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This indicates an influence of Nephrin on the localisation of Crb3, and an influence 
of Crb3b on the position of Crb3a. The only difference in these three applied constructs is 
the C-terminal domain, meaning this observed effect is based on the cytoplasmic 
interactions of Nephrin and Crb3 with proteins probably enhancing their stability. One 
possible link between Nephrin and Crb3 stability is the small GTPase Cdc42. Binding of 
Cdc42 to Par6 induces a conformational change in Par6, strengthening the association of 
the Par complex to the Crumbs complex and increasing the aPKC activity.28,34,132 This 
leads to an increased phosphorylation of Crumbs at the FERM domain, which was already 
shown in Drosophila.128 There, phosphorylation is crucial for the stability of Crumbs at the 
plasma membrane.128 Nephrin overexpression might lead to an increased binding of 
Cdc42 to IQGAP1, a direct interaction partner of Nephrin, keeping it from interacting with 
Par6, thereby, destabilising Crumbs at the plasma membrane.133–135  
The shared FERM binding domain of the Crb3 isoforms is essential for the proteins 
localisation and probably also for the stability at the plasma membrane, but it does not 
explain the difference in the plasma membrane stability when co-expressed in AB8 
cells.60,115,128 The FERM domains are the same, but if the phosphorylation of the FERM 
motif is crucial for the protein´s stability at the plasma membrane, the difference in the 
PDZ domains between Crb3a and Crb3b might explain the diverse stability when 
co-expressed. The binding of the Par complex through Crb3a PDZ domain leads probably 
to phosphorylation, thus stabilisation, of Crb3a through aPKC, while Crb3b does not 
interact with the Par complex (see also 4.3.2).35,62,128 Phosphorylation and stabilisation of 
Crb3b must be achieved through another unknown effector leading to a higher stability 
compared to Crb3a. 
 
Since live cell imaging of AB8 cells co-expressing Crb3 isoforms with fpNephrin-CT 
(4.2.4.) point to a common possibly connected transportation of Crumb3 with slit 
diaphragm proteins, it was of interest, to further investigate vesicle trafficking regarding 
Crb3 and fpNephrin-CT.  
Immunofluorescence analysis revealed that Crb3 isoforms and fpNephrin-CT are 
mainly transported via early (EEA1-positive) and recycling (Rab11-positive) endosomes 
in human podocytes (4.2.6.). Studies in MDCK cells showed that Crb3a is trafficked 
partially in Rab11- and EEA1-positive vesicles in MDCKs and mainly in Rab11-positive 
vesicles prior to mitosis in MDCK cells.74,115 It is possible, that co-localisation of Rab8 and 
Crb3 is found in MDCK cells, presenting primary cilia, since Rab8 together with Rab11 are 
known to be involved in primary ciliogenesis.136 However, podocytes fail to generate cilia, 
therefore, it is not surprising that no co-localisation was found with Rab8-positive 
vesicles. Early endosome´s cargo is either fated to be transported via late endosomes 
and consequently degraded in lysosomes, or it is recycled back to the plasma 
membrane.137 Only few Crb3/Nephrin-positive vesicles were found to be also LAMP2- 
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(lysosomes) or Rab7-positive (late endosomes) in AB8 cells (4.2.6.). Rab11 is thought to 
be critical for the exit of apical recycling endosomes to the plasma membrane.138  
Taken together, this indicates that Crb3 and Nephrin are rather recycled after a 
sufficient amount of protein is expressed and localised to the plasma membrane, than 
degraded and newly assembled, especially in podocytes.  
5.2.2 Crb3 in Madine Darby Canine Kidney Cells 
The immortalised podocyte cell line AB8 does not exhibit cell polarity, and growth 
in a collagen matrix, as done in a cyst formation assay, does not show any change in the 
polarisation of the cells (data not shown). The induction of junctional structures might be 
accompanied by a membrane extension, but it cannot be defined as an apical membrane 
expansion. Therefore, to further elucidate the role of Crb3b in epithelial cell polarity, a 
cyst formation assay was conducted with MDCK cells. The cyst formation assay with 
MDCK cells overexpressing Crb3a and Crb3b, respectively, shows a localisation for Crb3a 
and Crb3b at the apical membrane, but without an apical expansion for either Crb3 
isoform (4.2.7.). This is interesting, since previous reports of experiments with 
exogenous Crb3a in zebrafish and in MDCK cell lines stated an expansion of the apical 
membrane, an aspect that is regarding the podocyte´s huge apical membrane quite 
interesting.115,123 The expansion of the apical membrane in MDCK cells overexpressing 
Crb3a was observed in a cyst formation assay by the group of Margolis.115  
It is possible, that the distinct outcome of our cyst formation assays might be due 
to differences in the administration of the assay. Margolis´ group used two single-cell 
clone colony of MDCK cells with one moderate and one high expression level of 
GFP-Crb3a.115 Here, we did not use a single-cell clone colony for the assay but rather a 
mixed cell population. Retroviral-mediated GFP-Crb3 delivery generated a mixed MDCK 
cell population with diverse expression levels of GFP-Crb3. The use of a mixed cell 
population is less prone to errors regarding the phenotype, since the phenotype of a 
single-cell clone colony might be due to other defects in the genome of the MDCK cell. 
Quantitative analysis of observed effects, like cyst size and apical expansion, are 
probably more reliable in mixed cell populations than in single-cell colonies. Additionally, 
a longer incubation and growth time (seven or ten days) does not seem to be the reason 
for an observable apical expansion of the cysts due to Crb3 overexpression. 
While in our cyst formation assay Crb3a localises at the apical membrane and the 
junctional area, Crb3b mostly localises at the apical membrane without localisation at the 
junctional regions as staining with adherens junction protein marker ß-catenin shows. 
Previous studies reported that Crb3a  is found in MDCK cells and cysts at the apical 
membrane, tight junctions and primary cilia, while the only study about Crb3b states a 
localisation at the primary cilia in MDCK cells grown on transwell filters.50,62,115  
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Although there is no detectable apical expansion, the cysts still show a difference 
in growth compared to control cysts. Cysts expressing GFP-Crb3a or GFP-Crb3b are up to 
40% bigger than control cells expressing GFP alone (see 4.2.7). 
The question is, whether the increased cyst size is due to an increased 
proliferation and decreased apoptosis or due to an expansion of the cell volume? 
Quantification analysis of cyst size and lumen expansion reveals an increase in 
proliferation rather than cell volume expansion. This goes concomitant with studies in 
Drosophila, which demonstrate that an imbalance of DCrb expression, including 
overexpression, causes severe overproliferation through either interactions with the 
Hippo pathway or the Notch signalling pathway.139–142 The Hippo pathway is responsible 
for growth control through cell proliferation and apoptosis regulation, while Notch 
signalling is involved in cell differentiation and development.143,144 Interestingly, it seems 
that the FERM motif is responsible for growth regulation and induction of Hippo target 
genes in Drosophila, suggesting a possible influence of both mammalian Crb3 isoforms 
on this growth control pathway.139,140 
5.3 Analysis of Crb3-Pals1 Interactions 
Another crucial member of the Crumbs complex is Pals1. We showed that Pals1 is 
highly expressed in renal epithelial cells, especially in podocytes, with a similar 
distribution to Nephrin and Crb3 (see 4.1.).118 Immunofluorescence analysis revealed a 
recruitment of Pals1 to vesicles and the plasma membrane of AB8 cells through Crb3a. 
Although, co-expression with Crb3b does not seem to increase the Pals1-positive 
vesicular structures, the presence at the plasma membrane of Pals1 is slightly higher 
(4.3.1.). Direct interaction between Crb3a and Pals1 has been shown, but not much is 
known about the molecular and physiological features of Pals1.50 Since some of the Pals1 
domains are still not characterised regarding interaction partners and function, a possible 
interaction between Pals1 and Crb3b, particularly in podocytes, could be assumed (see 
Fig.4).  
Elucidating a possible interaction between Crb3b and Pals1, a yeast-two-hybrid 
approach showed no direct interaction between Crb3b and Pals1, while Crb3a and Pals1 
showed a direct link, as it was expected (4.3.2.).  
Knockdown of Pals1 in renal epithelial cells (MDCK) leads to a delay of tight 
junction formation, impaired development of luminal cysts and polarity defects in MDCK 
cyst formation assay, as does Crb3a knockdown.72 But Crb3a knockdown affects Pals1 
localisation in MDCK, while Pals1 knockdown does not impair Crb3a localisation or 
function, suggesting a upstream position of Crb3a in regard to Pals1 and explaining the 
recruitment of Pals1 through Crb3a to the plasma membrane in AB8 cells.72 Since there 
is no direct link between Crb3b and Pals1, the influence on Pals1 localisation in AB8 cells 
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has to be mediated by a different mechanism than direct recruitment. It is possible that 
Crb3b influences Pals1 localisation through an adaptor protein, not yet discovered. 
5.4 Analysis of Crumbs Complex In Vivo 
Acquired glomerular diseases are essentially tied to podocytes structure changes 
including cell polarity changes, followed by actin reorganization, loss of the slit 
diaphragm and foot process effacement with detachment of the GBM, finally leading to 
proteinuria and eventually to end-stage renal disease.  
Congenital glomerulopathies and podocytopathies are more likely connected to 
disturbances during kidney development. The renal cells of the nephron originate from 
the same progenitor cells. Since these cells undergo a mesenchymal-to-epithelial 
transition during the development of the nephron,  disruption of the nephron cell´s 
polarisation might be a major cause for congenital kidney diseases.  
A high Pals1 expression in murine and human glomerular podocytes (see 4.1.1. 
and 4.1.2.) and in immortalized human podocytes suggests an important role for Pals1 in 
podocyte´s polarity and function. A floxed Pals1 mouse line was used for in vivo 
experiments (see 2.12.1).118 
5.4.1 Podocyte-Specific Deletion of Pals1 
To accomplish a deletion of Pals1 only in podocytes, Pals1fl/fl mice were crossed 
with PodocinCre (PodCre) mice. After two crossings, a full knockout of Pals1 in podocytes 
was achieved (4.4.1.). 
Since Pals1 is highly expressed in glomeruli, and moreover co-localises with 
Nephrin in podocytes (4.1.1.), we expected the full knockout of Pals1 in podocytes to 
produce a similar phenotype to the podocyte-specific knockout of aPKCλ/ι. PodCre 
regulated deletion of aPKCλ/ι induced growth retardation, proteinuria and 
glomerulosclerosis several weeks after birth due to foot process effacement.125  
Surprisingly, no impairments in body size, weight or health condition within 12 
months after birth were observable in Pals1fl/fl PodCre+ mice. Furthermore, urine analysis 
demonstrated no signs of proteinuria, suggesting an intact slit diaphragm. Kidney section 
staining with Pals1 antibody verified the knockout of Pals1 in the podocytes. 
Taken together, a loss of Pals1 in podocytes does not severely impair the slit 
diaphragm or podocyte function.  
There are some possible explanations for the lack of a phenotype. First, Pals1 
does not play a role in podocyte polarity, which is rather unlikely given the importance in 
other epithelial tissues.72–74,77 Podocytes are post-mitotic with no capacity for substitution 
by cell division, meaning there might be no crucial need for Pals1 to maintain the cell 
structure after maturation.4,7 But it is possible that the absence of Pals1 leaves the 
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podocyte less adaptable to injury and change leading to a more severe reaction to 
damage. Hence, Pals1 might be required for the recovery of the kidney following injury.  
Secondly, Pals1 might not play a major role in the maintenance of the podocytes 
structure and function, but it could possibly be crucial during the initial establishment of  
podocyte polarity that, perhaps, precedes the formation of the final filtration barrier. The 
Cre recombinase is under the regulatory control of the NPHS2 promotor (podocin), which 
means the excision of Pals1 in the podocyte occurs when podocin is expressed. However, 
Podocin expression occurs late in the development of the glomerulus and podocyte, 
during the late capillary loop stage, when the cell polarity of the podocyte is already 
established.109,110  
The first theory could be addressed with an experimental model, as elaborated in 
future prospects (see 5.5).  
5.4.2 Kidney Development Specific Deletion of Pals1 
The second hypothesis was addressed by breeding the floxed Pals1 strain with a 
mouse strain expressing the Cre recombinase under regulatory control of the Six2 
promotor. The expression of Six2 starts at the early stages of kidney branching in a 
subset of metanephric mesenchyme (nephron progenitor cells). There, its expression is 
maintained throughout development, while in adult mouse kidneys no expression is 
detected.111–113  
Interestingly, even the deletion of only one Pals1 gene in the development of the 
kidney causes a strong and evident phenotype. Pals1wt/fl Six2Cre+ mice show severe 
impairments in body weight, body size and health conditions, leading to a median 
survival of approximately 40 days, most probably due to a nephrotic syndrome caused by 
massive proteinuria occurring within three weeks after birth (4.4.2.1. and 4.4.2.2.). 
Astonishingly, histological analysis of the kidney revealed glomerular changes and even a 
massive amount of cystic cavities in the cortex and medulla (4.4.2.3.). A very high 
number of cysts with an expansion from 1000µm2 up to 1.4mm2 pervaded the kidneys of 
Pals1wt/fl Six2Cre+ mice. While the overall size of the glomeruli remained the same as in 
Six2Cre- control kidneys, the number of glomeruli per kidney section was dramatically 
decreased, indicating a failure in glomerular development. The remaining glomeruli 
showed a significant expansion of the intraglomerular space, suggesting an additional 
damage to already developed glomeruli (4.4.2.4). A closer look at the glomeruli structure 
and morphology reveals denuded capillaries due to an extension of mesangial capillaries, 
and a detachment of podocytes from the glomerular basement membrane, leading to a 
loss of the podocytes. The podocytes detach from the GBM and attach to the parietal cell 
layer of the glomerular tuft developing crescent shaped scars (4.4.2.5.). In fact, Pals1wt/fl 
Six2Cre+ mice seem to develop a multiple kidney phenotype with similarities to polycystic 
kidney disease (PKD) and glomerulonephritis accompanied by a nephrotic syndrome. 
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The first similarity to a known phenotype is the formation of a high number of 
cystic cavities of various sizes, suggesting a polycystic kidney disease connection. 
Interestingly, Pals1 has been shown to interact via PATJ with polycystin-2 (PC2), a 
protein causing autosomal dominant polycystic kidney disease (ADPKD) and with a PC2 
transcriptional co-activator called TAZ.78,92,145 Characteristic for ADPKD is the 
development of cystic cavities, enormous in both size and quantity. The cysts of various 
sizes are spread throughout the cortex and medulla, deriving from every segment of the 
nephron, similar to the observed phenotype in Pals1wt/fl Six2Cre+ mice.146,147  
PC2 forms a Ca2+-permeable receptor-ion channel with PC1, the second protein 
involved in ADPKD. 148 PC2 together with PC1 acts as a mechanosensor at the primary 
cilium mediating extracellular calcium influx in response to the fluid flow.149 A lack of 
Pals1 could lead to a loss of PATJ, since Pals1 stabilises PATJ, and PATJ in turn controls 
PC2 activity, thereby controlling the calcium influx into the cell.72,73,78 Interestingly, PC1 
in ADPKD shows also defects in localisation and trafficking connected to apicobasal 
polarity, since in cystic epithelia it is localised intracellularly instead of being confined to 
the lateral membrane along the adherens junctions and focal adhesions.91 
In addition to the mentioned links of Pals1 to ADPKD, it was also reported that 
Pals1 interacts directly with nephrocystin-1 and nephrocystin-4, two proteins involved in 
the polycystic kidney disease nephronophthisis.150 Nephronophthisis is characterised by 
renal cysts rather restricted to the medulla/cortex border, derived from collecting ducts 
and distal tubules, unlike Pals1wt/fl Six2Cre+ mice. But, nephronophthisis leads to end-stage 
renal disease (ESRD) in children and young adults younger than 30 years and clinical 
manifestations, including growth retardation and progressive renal insufficiency, are 
similar to the Pals1wt/fl Six2Cre+ mice phenotype.92 NPHP1 and NPHP4 are located at the 
adherens junctions and basal body of the primary cilium.146 Crb3 and the Par complex 
have been shown to localise not only at the junctional structures but as well at the 
primary cilium, where Par3 also interacts with interflagellar transport (IFT) motor 
kinesin-2, linking the polarity proteins to IFT and the formation of cilia, which would 
suggest an direct influence of Pals1 on ciliogenesis.65 However, Pals1 has not been 
reported to be localised at the cilium, and since knockdown of Pals1 did not demonstrate 
a mislocalisation of Par3 or Crb3, its involvement with NPHP1 and NPHP4 is probably 
rather connected to the junctional area.72 Depletion of Pals1 leads to defects in the 
adherens junction formation, which might induce a mislocalisation of NPHP1/4 leading to 
renal cyst formation, through so far unknown pathways not connected to the ciliogenesis 
of the cells.75 
So the abnormal development of cystic cavities could be induced through 
pathways not directly connected to ciliogenesis or the known originators of PCD.  
For example, Mals-3 (mammalian Lin-7C) is a small PDZ domain protein that 
interacts and stabilises Pals1 in MDCK cells by binding to the second L27 domain of Pals1. 
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A knockdown of Mals-3 shows a defective tight junction and loss of Pals1.151 
Interestingly, knockout in neocortex progenitor cells during neurogenesis induces defects 
in the maintenance of apicobasal polarity. A full Mals-3 knockout in mice shows 
hypomorphic, cystic and fibrotic kidneys, caused by disruptions of the Crumbs and Dlg 
complex, but the cilia seem unaffected.152,153 Apparently, renal cysts are not necessarily 
caused by cilia dysfunctions. Although, defects in ciliogenesis of tubule specific Cdc42 
knockout mice with cysts in distal tubules and collecting ducts were observed, increased 
tubular cell proliferation and apoptosis were also reported.154 Defective cilia might not 
necessarily always be the cause of cystic development, but are rather a symptom of 
defective cell orientation and polarity.  
By way of example, Cdc42 regulates as well epithelial tissue morphogenesis 
through spindle orientation control during cell division.155 The correct spindle orientation 
is vital for the accurate cell orientation (planar cell polarity) during cell division. 
Disruption of cell and spindle orientation, inducing a non-directional cell division with 
cystic development, leads to multi-lumen phenotypes in MDCK cyst formation assays and 
abnormal growth in tubuli, which is a common feature of all polycystic diseases.146 A 
Pals1 depletion affects E-cadherin trafficking to the junctions which is crucial for 
adherens junction formation.75,156 The formation of the adherens junction through 
E-cadherin activates Cdc42, which in turn induces a translocation of aPKC from the 
nucleus to the cytoplasm and cell periphery by phosphorylation.44–46 Additionally, it has 
been reported that Par6 and aPKC regulate mitotic spindle orientation.157 Taken together, 
downregulation of Cdc42 or Par6 or aPKC induces multi-lumen phenotypes with spindle 
orientation dysfunctions in cyst formation assays, and furthermore, Cdc42 knockout mice 
show cystic kidneys, while Pals1 is ultimately responsible for the correct localisation and 
thereby function of all three proteins.154,155,157 This suggests that Pals1 is a major 
component of a protein network which controls not only apicobasal polarity and but also 
planar cell polarity through regulation of the spindle orientation and ultimately 
ciliogenesis. The importance of Pals1 in this network is emphasised by the fact that this 
severe cystic phenotype is caused by a reduction of Pals1 and not a complete knockout 
during nephrogenesis, as it is seen in the Cdc42 and Mals-3 knockout mice. 
 
In addition to the tubular phenotype of the Pals1wt/fl Six2Cre+ mice, a glomerular 
phenotype accompanied by a nephrotic syndrome was observed. Whole kidney sections 
showed an up to 90% reduced presence of glomeruli in Pals1wt/fl Six2Cre+ mice compared 
to control mice (4.4.2.4.). This might be due to the mentioned polarity defects with 
dysfunctioning mitotic spindle orientation during the development of the nephron (see 
1.2.). A reduction instead of a complete deletion of Pals1 could mean that the threshold 
of “not enough Pals1” to “barely enough Pals1” for a correct orientation during nephron 
development might be reached. Consequently, every branching tip and every developing 
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nephron would be dependent on the fact, if the amount of Pals1 in their cells crosses the 
threshold to “enough Pals1” for proper nephron generation. It is even imaginable, that 
tubular structures develop correctly at first, but are later not able to generate an intact 
renal corpuscle. Both theories might explain the huge lack of glomeruli in Pals1wt/fl
Six2Cre+ mice. The remaining glomeruli show a detachment of podocytes from the 
glomerular basement membrane, which goes concomitant with the detected proteinuria. 
However, proteinuria does not begin before two weeks of age, suggesting rather a 
degeneration of the already established glomeruli and filtration barrie, than an incorrect 
development. This was confirmed by electron microscopic analysis of the filtration barrier 
in Pals1wt/fl Six2Cre+ mice. The slit diaphragm appears to be normal and functional, with no 
differences to the control mice.  
If the renal corpuscle develops normally with an intact filtration barrier, than what 
leads to a degeneration of the glomeruli and podocytes?  
One possible cause for decomposition of a fully intact renal corpuscle is the 
extremely reduced number of functioning nephrons, due to the developmental defects. 
Various studies demonstrated a strong correlation between the number of nephrons in 
the kidney and the risk of developing a primary hypertension, which in turn would lead to 
a extension of the capillaries in the residual glomeruli as seen in figure 34 (4.4.2.5.).158–
162 To a limited extend, podocytes are able to compensate for the glomerular 
enlargement by hypertrophy, but usually that is not sufficient.93,101,102 Consequently, 
podocytes might detach from the GBM and podocyte depletion is the outcome. A 
significant loss of podocytes is associated with a progressive glomerulosclerosis. A 
depletion of less than 20% podocytes in a glomerulus results only in a mesangial 
expansion, while more than 20% exposes areas of the GBM leading to segmental 
sclerosis and severe proteinuria, as described for the Pals1wt/fl Six2Cre+ mice.90  
Reduction in the cell density of podocytes due to excessive compensatory 
glomerular hypertrophy, probably leads to the development of visceral cell defects that 
induce progressive glomerulosclerosis accompanied by a nephrotic syndrome. 
Compensatory hypertrophy of podocytes leads to an actin re-organisation especially in 
the foot processes, which is intimately linked to the GBM through α-/ß-dystroglycans, 
α3ß1- and αvß3-integrins.163–165 Dysfunction of cell matrix proteins due to actin 
disorganisation is linked to the detachment of the podocyte from the GBM, and 
consequently, to the loss of podocytes further applying hypertrophic stress on residual 
podocytes.166,167  
Taken together, the evaluation of the Pals1fl/fl PodCre+ and Pals1wt/fl Six2Cre+ mice 
reveals a minor role for Pals1 in the establishment and maintenance of the podocytes 
function, but an essential role in the development of the nephron, including podocyte 
precursor cells, probably through cell polarity determination and hence cell orientation. 
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These data argue for Pals1 as a crucial factor in the development of polycystic kidney 
diseases. 
5.5 Future Prospects 
Taken together, this work shows an important role for the Crumbs complex in 
renal epithelial cells that has to be further investigated and evaluated. 
To determine the role of Crb3b in renal epithelia, additional analysis have to be 
conducted. The role of the FERM domain for the stability of the Crumbs isoforms should 
be addressed by defining its importance for the localisation at the plasma membrane and 
the formation of the junctional structures. Therefore, analysis of the cells overexpressing 
either Crb3 isoform with mutated FERM domains could be performed. If the importance 
of the FERM motif is verified, interaction partners connected to the cytoskeleton should 
be addressed. This could be done via protein immunoprecipitation in immortalised human 
podocytes and MS/MS analysis, since yeast-two-hybrid approaches did not work. The 
same approach could be used for detecting interaction partners for the C-terminus of 
Crb3b in order to define the difference between the two splicing forms. Analysis of shared 
and Crb3b specific interaction partners could elucidate the role of Crb3b in podocytes.  
Furthermore, the junction-like formations that are induced through overexpression 
of either Crb3 isoform should be further investigated, e.g. via confocal microscopy and 
currently conducted FRAP analysis. Confocal microscopy would serve to better 
understand the structure of the junction-like formation. Fluorescence recovery after 
photobleaching (FRAP) is a method to analyse the dynamics of plasma membrane 
proteins. Recovery time and fluorescence intensity measurements of a protein tagged 
with GFP could give information about the velocity and amount of the newly assembled 
proteins. Moreover, this method will give evidence of how much of the plasma membrane 
protein is immobilised probably through strong fixed interactions with other proteins and 
how much is regularly internalised and replaced.   
Another method is the single particle trafficking analysis, which surveys the speed 
and direction dynamics of single Crb3-postive vesicles endocytosed by the cell. 
Additionally, this method reveals the dependence of the vesicles on either actin or 
microtubules. 
For further investigations of Pals1 and its role in the renal epithelia, both mouse 
lines discussed in this work should be utilised. Pals1fl/fl PodCre+ mice can be used for an 
experimental model. In order to determine whether Pals1 is required for the response to 
renal injury in podocytes, Pals1fl/fl PodCre+ mice could be injected with adriamycin, a 
chemical inducing nephropathy.168 Comparison between Pals1fl/fl PodCre+ mice and control 
mice would show if a full knockout of Pals1 in podocytes leads to a more severe damage 
or a delayed recovery in the podocyte.  
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Pals1wt/fl Six2Cre+ mice should be further examined. Kidney sections and analysis of 
glomeruli and slit diaphragm of mice of different age stages, including the age before 
proteinuria is detectable (younger than two weeks), would show how the damage in the 
glomerulus and especially the podocytes progresses and develops. Additionally, kidney 
sections should be surveyed due to apoptosis, proliferation and ciliogenesis in tubuli, to 
determine the cause for the cystic development. Staining of matrix adhesion proteins 
could elucidate their role in the detachment of the podocytes from the GBM.  
Furthermore, a third mouse knockout line with Pals1 depletion regulated by 
Cadherin16 expression could be utilised to further investigate the role of Pals1 in the 
tubuli and cystic development.  
In vitro studies, with knockdown of Pals1 in MDCK cells and immunofluorescence 
analysis of the different mitosis stages, could reveal a role for Pals1 in spindle orientation 
and possibly ciliogensis, similar to Crb3a.115 
Last but not least, the role of Crb3 in podocytes could be addressed with a PodCre 
induced knockout in a Crb3 conditional knockout mouse line which is currently being 
established by the group of B. Margolis.  
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